Review article
The Prognostic Role of Lymphatic Vessel Density in Papillary Thyroid Carcinoma: A Systematic Review and Meta‐analysis
Cancer Diagnosis & Prognosis
Sep-Oct;
5(5):
542-551
DOI: 10.21873/cdp.10468
Research articles
Risk Factors for Infusion Reactions Associated With Rituximab Therapy
Cancer Diagnosis & Prognosis
Sep-Oct;
5(5):
552-556
DOI: 10.21873/cdp.10469
GLIM Criteria as Prognostic Factor in Patients Undergoing Adjuvant S‐1 Chemotherapy for Biliary Tract Cancer
Cancer Diagnosis & Prognosis
Sep-Oct;
5(5):
557-565
DOI: 10.21873/cdp.10470
Surgical Measures Improving Functional Limitations of the Masticatory System, Aesthetic Deficits, and Skeletal Malformations in Neurofibromatosis Type 1‐associated Hemifacial Diffuse Plexiform Neurofibroma Complicated by Rapidly Growing Midfacial Peripheral Nerve Sheath Tumor
Cancer Diagnosis & Prognosis
Sep-Oct;
5(5):
566-582
DOI: 10.21873/cdp.10471
Treatment Response and Survival in Thyroid Transcription Factor‐1 Negative Non‐squamous Non‐small Cell Lung Cancer
Cancer Diagnosis & Prognosis
Sep-Oct;
5(5):
583-590
DOI: 10.21873/cdp.10472
Efficacy of Durvalumab‐Tremelimumab Treatment in Combination With Locoregional Therapy in Unresectable Hepatocellular Carcinoma: A Preliminary Study
Cancer Diagnosis & Prognosis
Sep-Oct;
5(5):
591-596
DOI: 10.21873/cdp.10473
Prognostic Impact of Sarcopenia on Clinical Outcomes in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Treated With Immune Checkpoint Inhibitors
Cancer Diagnosis & Prognosis
Sep-Oct;
5(5):
597-605
DOI: 10.21873/cdp.10474
Young Women With Endometrial Cancer: A Portuguese Perspective
Cancer Diagnosis & Prognosis
Sep-Oct;
5(5):
606-613
DOI: 10.21873/cdp.10475
Eradication of Extensive Lymph‐Node, Bone and Pleural Metastases of a Breast‐Cancer Patient Treated With Radiation, Immunotherapy and Oral Recombinant Methioninase
Cancer Diagnosis & Prognosis
Sep-Oct;
5(5):
614-619
DOI: 10.21873/cdp.10476
Definitive Diagnosis of Angiomatoid Fibrous Histiocytoma Using Dual DNA/RNA Genomic Profiling
Cancer Diagnosis & Prognosis
Sep-Oct;
5(5):
620-624
DOI: 10.21873/cdp.10477
MRS Imaging as Complement to MRI in the Post‐treatment Follow‐up of Glial Brain Tumors
Cancer Diagnosis & Prognosis
Sep-Oct;
5(5):
625-633
DOI: 10.21873/cdp.10478
Asymptomatic Troponin Elevation and Early Mortality Following Immune Checkpoint Inhibitor Therapy in Patients Without Cardiac Adverse Events
Cancer Diagnosis & Prognosis
Sep-Oct;
5(5):
634-641
DOI: 10.21873/cdp.10479
A Rare Case of Femur Metastasis from Brain Meningioma
Cancer Diagnosis & Prognosis
Sep-Oct;
5(5):
642-646
DOI: 10.21873/cdp.10480
Safety of Enfortumab Vedotin Plus Pembrolizumab in Hemodialysis Patients With Metastatic Urothelial Carcinoma: Case Report
Cancer Diagnosis & Prognosis
Sep-Oct;
5(5):
647-651
DOI: 10.21873/cdp.10481
Review article
The Role of Axl Inhibition and Immune Checkpoint Blockade in Non-small Cell Lung Cancer: Current Understanding and Treatment Strategies
Cancer Diagnosis & Prognosis
Jul-Aug;
5(4):
417-428
DOI: 10.21873/cdp.10455
Research articles
Molecular Insights into Gastric Cancer: A Comparative Analysis of Asian and White Populations
Cancer Diagnosis & Prognosis
Jul-Aug;
5(4):
429-436
DOI: 10.21873/cdp.10456
Impact of Pre-treatment Proteinuria Progression on the Risk of Increased Proteinuria During Ramucirumab Therapy
Cancer Diagnosis & Prognosis
Jul-Aug;
5(4):
437-452
DOI: 10.21873/cdp.10457
Investigation of the Biological Properties of Non-small Cell Lung Cancer Using Three-dimensional Computed Tomography Images
Cancer Diagnosis & Prognosis
Jul-Aug;
5(4):
453-460
DOI: 10.21873/cdp.10458
A Case of Non-islet Cell Tumor Hypoglycemia Secondary to Metastatic Rectal Adenocarcinoma: Presentation, Management, and Literature Review
Cancer Diagnosis & Prognosis
Jul-Aug;
5(4):
461-468
DOI: 10.21873/cdp.10459
Rare Head and Neck Neuroendocrine Neoplasms: A Retrospective Study of Prognosis and Treatment Outcomes
Cancer Diagnosis & Prognosis
Jul-Aug;
5(4):
469-477
DOI: 10.21873/cdp.10460
Characteristics and Outcomes of Patients Who Underwent Curative Resection for Colorectal Cancer Local Recurrence
Cancer Diagnosis & Prognosis
Jul-Aug;
5(4):
478-484
DOI: 10.21873/cdp.10461
Angiotensin Receptor Neprilysin Inhibitors for Hypertension and Proteinuria Management During Atezolizumab/Bevacizumab Treatment for Hepatocellular Carcinoma
Cancer Diagnosis & Prognosis
Jul-Aug;
5(4):
485-491
DOI: 10.21873/cdp.10462
Clinical Significance of HER2-low Expression in Triple-negative Breast Cancer: A Retrospective Multicenter Study
Cancer Diagnosis & Prognosis
Jul-Aug;
5(4):
492-498
DOI: 10.21873/cdp.10463
Predictive Value of Incidental Cross-Sectional Imaging for Prediction of Skeletal Events in Patients With Prostate Cancer
Cancer Diagnosis & Prognosis
Jul-Aug;
5(4):
499-505
DOI: 10.21873/cdp.10464
The Impact of Lymphoscintigraphy Visualization on the Prognosis of Early Breast Cancer Patients Undergoing Sentinel Node Biopsy: A 20-year, Single-center Experience
Cancer Diagnosis & Prognosis
Jul-Aug;
5(4):
506-514
DOI: 10.21873/cdp.10465
Immunohistochemical Expression of IRE1 and PERK in Breast Cancer: Associations With Clinicopathological Characteristics and Survival Outcomes
Cancer Diagnosis & Prognosis
Jul-Aug;
5(4):
515-529
DOI: 10.21873/cdp.10466
Expression and Prognostic Implication of the Nuclear Receptors Farnesoid X Receptor and Pregnane X Receptor in Human Cholangiocarcinoma
Cancer Diagnosis & Prognosis
Jul-Aug;
5(4):
529-541
DOI: 10.21873/cdp.10467
Research articles
Comparing Two Gene Expression Profile Tests to Standard of Care for Identifying Patients With Cutaneous Melanoma at Low Risk of Sentinel Lymph Node Positivity
Cancer Diagnosis & Prognosis
May-June;
5(3):
261-267
DOI: 10.21873/cdp.10438
The Role of p300 and TMPRSS2 in Prostate Cancer: Immunohistochemical Perspectives and Gleason Correlations
Cancer Diagnosis & Prognosis
May-June;
5(3):
268-279
DOI: 10.21873/cdp.10439
Perspective on an Innovative Curative Strategy for Peritoneal Metastasis Involving Peritonectomy, Hyperthermic Intraperitoneal Chemotherapy, and Adjuvant Chemotherapy Identified as Effective in the Histoculture Drug Response Assay (HDRA)
Cancer Diagnosis & Prognosis
May-June;
5(3):
280-284
DOI: 10.21873/cdp.10440
Relationship Between T790M Allele Frequency and Therapeutic Effects Before and After EGFR-TKI Administration Using Droplet Digital PCR in Non-small-cell Lung Cancer With EGFR Mutation
Cancer Diagnosis & Prognosis
May-June;
5(3):
285-299
DOI: 10.21873/cdp.10441
Dosimetric Comparison of Coplanar, Non-coplanar, and Mixed-Arc VMAT for Head and Face Skin Cancers: A Multi-scenario Analysis
Cancer Diagnosis & Prognosis
May-June;
5(3):
300-312
DOI: 10.21873/cdp.10442
Preoperative Predictive Factors for Seminal Vesicle Invasion (pT3b) in Robotic-assisted Radical Prostatectomy
Cancer Diagnosis & Prognosis
May-June;
5(3):
313-318
DOI: 10.21873/cdp.10443
Facial Diffuse Plexiform Neurofibroma-associated Mandibular Deformities: Surgical Interventions and Monitoring of Treatment Results in a Patient for Over 40 Years
Cancer Diagnosis & Prognosis
May-June;
5(3):
319-329
DOI: 10.21873/cdp.10444
Recurrent Diffuse Neurofibroma of the Mandibular Anterior Lingual Alveolar Process Associated With Dental and Skeletal Changes in Neurofibromatosis Type 1
Cancer Diagnosis & Prognosis
May-June;
5(3):
330-343
DOI: 10.21873/cdp.10445
Analysis of Early Progression in Advanced Renal Cell Carcinoma Treated With Nivolumab Plus Ipilimumab
Cancer Diagnosis & Prognosis
May-June;
5(3):
344-352
DOI: 10.21873/cdp.10446
Lymphocyte‐to‐C‐reactive Protein Ratio as an Independent Prognostic Factor for Patients With Gastric Cancer Who Received Curative Treatment
Cancer Diagnosis & Prognosis
May-June;
5(3):
353-362
DOI: 10.21873/cdp.10447
Multicenter Retrospective Analysis of Pulmonary Sarcomatoid Carcinoma Clinically Diagnosed Using Small Biopsy Specimens
Cancer Diagnosis & Prognosis
May-June;
5(3):
363-369
DOI: 10.21873/cdp.10448
The Potential of the C-Reactive Protein-Albumin-Lymphocyte (CALLY) Index as a Prognostic Biomarker in Colorectal Cancer
Cancer Diagnosis & Prognosis
May-June;
5(3):
370-377
DOI: 10.21873/cdp.10449
Factors Influencing Severe Hematologic Toxicity Following Niraparib Therapy in Patients With Ovarian Cancer
Cancer Diagnosis & Prognosis
May-June;
5(3):
378-385
DOI: 10.21873/cdp.10450
Prognostic Factors in EGFR Mutation‐positive Patients With Bone Metastases from Lung Adenocarcinoma
Cancer Diagnosis & Prognosis
May-June;
5(3):
386-395
DOI: 10.21873/cdp.10451
Pneumocystis Pneumonia in a Patient With Colorectal Cancer Receiving Bevacizumab and mFOLFOX6 Therapy
Cancer Diagnosis & Prognosis
May-June;
5(3):
396-403
DOI: 10.21873/cdp.10452
Aggressive Orbital Dedifferentiated Liposarcoma With Osseus Components in a Young Woman
Cancer Diagnosis & Prognosis
May-June;
5(3):
404-409
DOI: 10.21873/cdp.10453
Advanced Metastatic Malignant Triton Tumor in Neurofibromatosis Type 1: A Case Report and Management Challenges
Cancer Diagnosis & Prognosis
May-June;
5(3):
410-416
DOI: 10.21873/cdp.10454
Research articles
Impact of Body Mass Index on Survival After Docetaxel Chemotherapy for Metastatic Castration‐resistant Prostate Cancer
Cancer Diagnosis & Prognosis
Mar-Apr;
5(2):
138-145
DOI: 10.21873/cdp.10423
The Role of HMGA1 and Height in Breast Cancer Risk and Prognosis: Insights from UK Biobank Data
Cancer Diagnosis & Prognosis
Mar-Apr;
5(2):
146-152
DOI: 10.21873/cdp.10424
Long‐term Outcomes of Biological Reconstruction for Primary Bone Sarcoma of the Humerus
Cancer Diagnosis & Prognosis
Mar-Apr;
5(2):
153-161
DOI: 10.21873/cdp.10425
Third Liver Resection for Re‐recurrent Hepatocellular Carcinoma: Assessment of the Prognostic Factors of Long‐term Survival
Cancer Diagnosis & Prognosis
Mar-Apr;
5(2):
162-170
DOI: 10.21873/cdp.10426
External Validation of an Extended Prognostic Assessment Model in Patients With Brain Metastases from Small‐cell Lung Cancer
Cancer Diagnosis & Prognosis
Mar-Apr;
5(2):
171-178
DOI: 10.21873/cdp.10427
Predictive Factors for the Efficacy of Head and Neck Photoimmunotherapy and Optimization of Treatment Schedules
Cancer Diagnosis & Prognosis
Mar-Apr;
5(2):
179-188
DOI: 10.21873/cdp.10428
Long‐term Outcomes of Salvage Radiotherapy Using TomoTherapy With Image‐guided Radiotherapy for Postoperative Prostate Cancer Patients
Cancer Diagnosis & Prognosis
Mar-Apr;
5(2):
189-197
DOI: 10.21873/cdp.10429
Outcomes of Liposomal Irinotecan With 5‐FU and Leucovorin in Patients With Metastatic Pancreatic Cancer and Borderline Performance Status
Cancer Diagnosis & Prognosis
Mar-Apr;
5(2):
198-206
DOI: 10.21873/cdp.10430
Dose Reduction of EGFR‐TKIs for EGFR‐positive Non‐small Cell Lung Cancer: A Retrospective Study
Cancer Diagnosis & Prognosis
Mar-Apr;
5(2):
207-215
DOI: 10.21873/cdp.10431
Clinicopathological Features and Prognosis of Unresectable Colorectal Cancer With the BRAF V600E Mutation
Cancer Diagnosis & Prognosis
Mar-Apr;
5(2):
216-222
DOI: 10.21873/cdp.10432
Evaluation of PI3K Levels and miRNA124‐5p Expression Levels in Serum Samples from Patients With Lung Cancer
Cancer Diagnosis & Prognosis
Mar-Apr;
5(2):
223-229
DOI: 10.21873/cdp.10433
Preoperative Visitation Effect on Quality of Life of Patients Undergoing Transarterial Chemoembolization for Hepatocellular Carcinoma
Cancer Diagnosis & Prognosis
Mar-Apr;
5(2):
230-237
DOI: 10.21873/cdp.10434
Comprehensive Analysis of Osteosarcoma Referral Letters: Insights into Medical Collaboration and Diagnostic Practices at Our Hospital
Cancer Diagnosis & Prognosis
Mar-Apr;
5(2):
238-243
DOI: 10.21873/cdp.10435
Malignant Peripheral Nerve Sheath Tumor (MPNST) Arising from Orbital Plexiform Neurofibroma in a Small Child With Neurofibromatosis Type 1
Cancer Diagnosis & Prognosis
Mar-Apr;
5(2):
244-254
DOI: 10.21873/cdp.10436
A Case of Infraorbital B‐cell Lymphoma Masquerading as an Abscess
Cancer Diagnosis & Prognosis
Mar-Apr;
5(2):
255-260
DOI: 10.21873/cdp.10437
Research articles
High Tumoral KPNA2 Expression Is a Potential Biomarker for Poor Prognosis in Advanced Neuroblastoma Patients
Cancer Diagnosis & Prognosis
Jan-Feb;
5(1):
1-7
DOI: 10.21873/cdp.10404
Elevated-c-MYC-expressing Fibrosarcoma Cells With Acquired Gemcitabine Resistance Remain Sensitive to Recombinant Methioninase: A Potential Clinical Strategy for a Recalcitrant Disease
Cancer Diagnosis & Prognosis
Jan-Feb;
5(1):
8-14
DOI: 10.21873/cdp.10405
Impact of C-FOS/C-JUN Transcriptional Factors Co-Expression in Non–small Cell Lung Carcinoma
Cancer Diagnosis & Prognosis
Jan-Feb;
5(1):
15-20
DOI: 10.21873/cdp.10406
Complete Response (CR) in a Previously-progressing Chronic Lymphocytic Leukemia (CLL) Patient Treated With Methionine Restriction in Combination With First-line Chemotherapy
Cancer Diagnosis & Prognosis
Jan-Feb;
5(1):
21-26
DOI: 10.21873/cdp.10407
Prostate Cancer Patient With Lymph-node Metastasis Treated Only With Methionine Restriction Has Stable Disease for Two Years Demonstrated With PET/CT and PSMA-PET Scanning and PSA Testing
Cancer Diagnosis & Prognosis
Jan-Feb;
5(1):
27-31
DOI: 10.21873/cdp.10408
Tumor β-Catenin Expression Associated With Poor Prognosis to Anti-PD-1 Antibody Monotherapy in Non-small Cell Lung Cancer
Cancer Diagnosis & Prognosis
Jan-Feb;
5(1):
32-41
DOI: 10.21873/cdp.10409
Effect of Diabetes on Outcomes in Patients With Incurable/Unresectable and Advanced/Recurrent Colorectal Cancer Receiving mFOLFOX6
Cancer Diagnosis & Prognosis
Jan-Feb;
5(1):
42-48
DOI: 10.21873/cdp.10410
Clinical and Pathological Analysis of Perianal Paget’s Disease: A Case Report and Review of 89 Cases
Cancer Diagnosis & Prognosis
Jan-Feb;
5(1):
49-55
DOI: 10.21873/cdp.10411
Current Status of Sequential Treatment for Castration-resistant Prostate Cancer: A Retrospective Analysis
Cancer Diagnosis & Prognosis
Jan-Feb;
5(1):
56-61
DOI: 10.21873/cdp.10412
Remnant Stomach Influx Reduces Esophageal Reflux and Malnutrition After Proximal Gastrectomy With Double Tract Reconstruction
Cancer Diagnosis & Prognosis
Jan-Feb;
5(1):
62-71
DOI: 10.21873/cdp.10413
Impact of Changes in Psoas Muscle Index on Prognosis in Patients With Colorectal Liver Metastases
Cancer Diagnosis & Prognosis
Jan-Feb;
5(1):
72-82
DOI: 10.21873/cdp.10414
Treatment Strategies in Elderly Patients With Operable, Hormone Receptor-negative Breast Cancer
Cancer Diagnosis & Prognosis
Jan-Feb;
5(1):
83-88
DOI: 10.21873/cdp.10415
Prognostic Value of the Modified Cachexia Index in Colorectal Cancer Patients Undergoing Curative Surgery
Cancer Diagnosis & Prognosis
Jan-Feb;
5(1):
89-94
DOI: 10.21873/cdp.10416
Association of Pretreatment Albumin-bilirubin Grade With Hepatotoxicity and Efficacy in EGFR-TKIs Therapy for NSCLC
Cancer Diagnosis & Prognosis
Jan-Feb;
5(1):
95-104
DOI: 10.21873/cdp.10417
Outcomes of Combined Atezolizumab Plus Chemotherapy in Non-small Cell Lung Cancer Patients in Clinical Practice
Cancer Diagnosis & Prognosis
Jan-Feb;
5(1):
105-114
DOI: 10.21873/cdp.10418
The Global Immune-Nutrition-Information Index (GINI) Is an Independent Prognostic Factor for Esophageal Cancer Patients Who Receive Curative Treatment
Cancer Diagnosis & Prognosis
Jan-Feb;
5(1):
115-121
DOI: 10.21873/cdp.10419
Clinical Outcomes of Micropapillary Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy
Cancer Diagnosis & Prognosis
Jan-Feb;
5(1):
122-126
DOI: 10.21873/cdp.10420
Successful Salvage of Four Cases of Unresectable Papillary Thyroid Cancer Following Lenvatinib Administration
Cancer Diagnosis & Prognosis
Jan-Feb;
5(1):
127-131
DOI: 10.21873/cdp.10421
Prognostic Significance of Lymphocyte-to-Monocyte Ratio in Patients With Unresectable Biliary Tract Cancer Undergoing Systemic Chemotherapy
Cancer Diagnosis & Prognosis
Jan-Feb;
5(1):
132-137
DOI: 10.21873/cdp.10422
Review article
Androgen Receptor Signaling Inhibitor Withdrawal Syndrome After Castration-resistant Prostate Cancer
Cancer Diagnosis & Prognosis
Nov-Dec;
4(6):
684-688
DOI: 10.21873/cdp.10382
Research articles
Risk Factors for Adhesive Small Bowel Obstruction After Liver Cancer Surgery
Cancer Diagnosis & Prognosis
Nov-Dec;
4(6):
689-695
DOI: 10.21873/cdp.10383
Thrombocytopenia With High C-reactive Protein in Myeloma Patients Treated With Proteasome Inhibitor and/or Immunomodulatory Drugs
Cancer Diagnosis & Prognosis
Nov-Dec;
4(6):
696-705
DOI: 10.21873/cdp.10384
PSA Kinetics Affect Prognosis in Patients With Castration-resistant Prostate Cancer Treated With Enzalutamide
Cancer Diagnosis & Prognosis
Nov-Dec;
4(6):
706-714
DOI: 10.21873/cdp.10385
Cribriform Pattern Is a Predictive Factor of PSA Recurrence in Patients Receiving Radiotherapy After Prostatectomy
Cancer Diagnosis & Prognosis
Nov-Dec;
4(6):
715-721
DOI: 10.21873/cdp.10386
Factors Associated With Infusion Reactions in Patients With Breast Cancer Receiving Trastuzumab
Cancer Diagnosis & Prognosis
Nov-Dec;
4(6):
722-728
DOI: 10.21873/cdp.10387
Five-item Modified Frailty Index in Elderly Patients Undergoing Laparoscopic Colorectal Surgery Predicts Postoperative Complications
Cancer Diagnosis & Prognosis
Nov-Dec;
4(6):
729-734
DOI: 10.21873/cdp.10388
The Prognostic Significance of Plasma Beta2-Glycoprotein I Levels in Hepatocellular Carcinoma Patients
Cancer Diagnosis & Prognosis
Nov-Dec;
4(6):
735-742
DOI: 10.21873/cdp.10389
Short-term Outcomes of Robotic Left Colectomy Reconstructed by Intracorporeal Overlap Anastomosis for Left-sided Colon Cancer: A Single-center Report from Japan
Cancer Diagnosis & Prognosis
Nov-Dec;
4(6):
743-747
DOI: 10.21873/cdp.10390
C-reactive Protein-albumin-lymphocyte Index as a Novel Biomarker for Progression in Patients Undergoing Surgery for Renal Cancer
Cancer Diagnosis & Prognosis
Nov-Dec;
4(6):
748-753
DOI: 10.21873/cdp.10391
High Subcutaneous Adipose Tissue Radiodensity Predicts Poor Prognosis in Patients With Gastric Cancer
Cancer Diagnosis & Prognosis
Nov-Dec;
4(6):
754-761
DOI: 10.21873/cdp.10392
Correlation Between Serum and Tissue SIRT1 Levels in Patients With Esophageal Squamous Cell Carcinoma
Cancer Diagnosis & Prognosis
Nov-Dec;
4(6):
762-768
DOI: 10.21873/cdp.10393
Efficacy of Paclitaxel and Cetuximab in Recurrent/Metastatic Oral Cancer Cases Following Superselective Intraarterial Chemoradiotherapy: A Retrospective Cohort Study
Cancer Diagnosis & Prognosis
Nov-Dec;
4(6):
769-774
DOI: 10.21873/cdp.10394
The Role of the NOLUS Score in Predicting pCR and iDFS in HR-positive HER2-negative Early Breast Cancer Patients who Received Neoadjuvant Chemotherapy
Cancer Diagnosis & Prognosis
Nov-Dec;
4(6):
775-782
DOI: 10.21873/cdp.10395
Risk Classification of Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin
Cancer Diagnosis & Prognosis
Nov-Dec;
4(6):
783-788
DOI: 10.21873/cdp.10396
Prediction of Treatment Response Based on Nutritional Status and Tumor Immunity in Oropharyngeal Cancer Patients Treated With Chemoradiotherapy
Cancer Diagnosis & Prognosis
Nov-Dec;
4(6):
789-796
DOI: 10.21873/cdp.10397
Short-term Outcomes of Robot-assisted Colectomy Using the Overlap Method for Right-sided Colon Cancer
Cancer Diagnosis & Prognosis
Nov-Dec;
4(6):
797-801
DOI: 10.21873/cdp.10398
Drainage Fluid Amylase as a Biomarker for the Detection of Anastomotic Leakage After Low Anterior Resection of Rectal Cancer: A Two-center Study
Cancer Diagnosis & Prognosis
Nov-Dec;
4(6):
802-807
DOI: 10.21873/cdp.10399
Effectiveness of Steerable Microcatheters During Transarterial Chemoembolization for Hepatocellular Carcinoma
Cancer Diagnosis & Prognosis
Nov-Dec;
4(6):
808-813
DOI: 10.21873/cdp.10400
Bilateral Parotid Gland Oncocytoma Mimicking Oropharyngeal Cancer Metastasis: A Case Report from a Radiation Oncologist’s Perspective
Cancer Diagnosis & Prognosis
Nov-Dec;
4(6):
814-818
DOI: 10.21873/cdp.10401
Bilateral Dermoid Ovarian Cysts in a Young Woman – A Case Report and Literature Review
Cancer Diagnosis & Prognosis
Nov-Dec;
4(6):
819-824
DOI: 10.21873/cdp.10402
Desmoplastic Fibroblastoma (Collagenous Fibroma) of the Knee: A Case Report and Literature Review
Cancer Diagnosis & Prognosis
Nov-Dec;
4(6):
825-827
DOI: 10.21873/cdp.10403
Review articles
The Role of Microsurgery and Fluorescent-reporter Genes in Establishing Mouse Models for Real-Time Imaging of Metastatic Cancer-Cell Trafficking and Colony Formation: A Revolutionary and Disruptive Technology for Metastasis Research
Cancer Diagnosis & Prognosis
Sep-Oct;
4(5):
544-557
DOI: 10.21873/cdp.10362
Immunotherapeutic Innovations in Clear Cell Renal Cell Carcinoma: Current Strategies and Future Directions
Cancer Diagnosis & Prognosis
Sep-Oct;
4(5):
558-562
DOI: 10.21873/cdp.10363
Research articles
Imaging Transgenic Nude Mice Expressing Spectrally-distinct Fluorescent Reporters Emitting From Blue to Far Red Light With One Instrument With Single-nanometer-tuning of Laser-excitation Fluorescence
Cancer Diagnosis & Prognosis
Sep-Oct;
4(5):
563-566
DOI: 10.21873/cdp.10364
Putative Dual Roles of Bone Morphogenetic Protein 8B (BMP8B) in Disease Progression of Gastric Cancer
Cancer Diagnosis & Prognosis
Sep-Oct;
4(5):
567-578
DOI: 10.21873/cdp.10365
Diagnostic Impacts of Aldehyde Dehydrogenase 2 Genetic Variants on Hepatocellular Carcinoma Susceptibility
Cancer Diagnosis & Prognosis
Sep-Oct;
4(5):
579-585
DOI: 10.21873/cdp.10366
Caspase 3 Expression Profiles in Meningioma Subtypes Based on Tissue Microarray Analysis
Cancer Diagnosis & Prognosis
Sep-Oct;
4(5):
586-591
DOI: 10.21873/cdp.10367
Association of PARP1 Expression Levels and Clinical Parameters in Different Leukemic Subtypes With BCR::ABL1 p190+ Translocation
Cancer Diagnosis & Prognosis
Sep-Oct;
4(5):
592-598
DOI: 10.21873/cdp.10368
Comparison of the Preoperative MRI Evaluation of Glandular Tissue in Subcutaneous Mastectomy and its Influence on the Implant Volume
Cancer Diagnosis & Prognosis
Sep-Oct;
4(5):
599-604
DOI: 10.21873/cdp.10369
Association of Oncotype-DX HER2 Single Gene Score With HER2 Expression Assessed by Immunohistochemistry in HER2-low Breast Cancer
Cancer Diagnosis & Prognosis
Sep-Oct;
4(5):
605-610
DOI: 10.21873/cdp.10370
Comparison of Local Recurrence Between LEN-TACE and TACE for Hepatocellular Carcinoma According to Lipiodol Accumulation
Cancer Diagnosis & Prognosis
Sep-Oct;
4(5):
611-616
DOI: 10.21873/cdp.10371
Risk Factor for Rash in Patients Receiving Cytarabine and Idarubicin Induction Therapy for Acute Myeloid Leukemia
Cancer Diagnosis & Prognosis
Sep-Oct;
4(5):
617-622
DOI: 10.21873/cdp.10372
Atezolizumab Plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma: Real-life Experience from a Single Tertiary Centre in Spain and ALBI Score as a Survival Prognostic Factor
Cancer Diagnosis & Prognosis
Sep-Oct;
4(5):
623-630
DOI: 10.21873/cdp.10373
Disproportionality Analysis of Osimertinib-related Adverse Events in Elderly Patients Using the Japanese Pharmacovigilance Database
Cancer Diagnosis & Prognosis
Sep-Oct;
4(5):
631-637
DOI: 10.21873/cdp.10374
Predictive Value of the Prostate-specific Antigen Doubling Time for the Effectiveness of Metastasis-directed Radiotherapy in Patients With Oligometastases After Radical Treatment for Non-metastatic Prostate Cancer
Cancer Diagnosis & Prognosis
Sep-Oct;
4(5):
638-645
DOI: 10.21873/cdp.10375
Predictors of Progression to Castration-resistant Prostate Cancer After Radical Prostatectomy in High-risk Prostate Cancer Patients
Cancer Diagnosis & Prognosis
Sep-Oct;
4(5):
646-651
DOI: 10.21873/cdp.10376
The Mayo Adhesive Probability Score as a Predictor of Postoperative Renal Function in Robot-assisted Partial Nephrectomy
Cancer Diagnosis & Prognosis
Sep-Oct;
4(5):
652-657
DOI: 10.21873/cdp.10377
Interval to Recurrence Affects Survival in Recurrent Head and Neck Squamous Cell Carcinoma
Cancer Diagnosis & Prognosis
Sep-Oct;
4(5):
658-666
DOI: 10.21873/cdp.10378
Effect of Perioperative Physical Activity on Skeletal Muscle Loss 6 Months After Esophageal Cancer Surgery
Cancer Diagnosis & Prognosis
Sep-Oct;
4(5):
667-674
DOI: 10.21873/cdp.10379
Prognostic Impact of Tumor Growth Rate During Second-line Chemotherapy in Patients With Gastric Cancer
Cancer Diagnosis & Prognosis
Sep-Oct;
4(5):
675-679
DOI: 10.21873/cdp.10380
Successful Use of Cemiplimab in a Very Elderly Patient With Cutaneous Squamous Cell Carcinoma
Cancer Diagnosis & Prognosis
Sep-Oct;
4(5):
680-683
DOI: 10.21873/cdp.10381
Review article
Efficacy of Magnesium Supplementation in Cancer Patients Developing Hypomagnesemia Due to Anti-EGFR Antibody: A Systematic Review
Cancer Diagnosis & Prognosis
Jul-Aug;
4(4):
390-395
DOI: 10.21873/cdp.10337
Research articles
Synergy of Rapamycin and Methioninase on Colorectal Cancer Cells Requires Simultaneous and Not Sequential Administration: Implications for mTOR Inhibition
Cancer Diagnosis & Prognosis
Jul-Aug;
4(4):
396-401
DOI: 10.21873/cdp.10338
The Combination of Methionine Restriction and Docetaxel Synergistically Arrests Androgen-independent Prostate Cancer But Not Normal Cells
Cancer Diagnosis & Prognosis
Jul-Aug;
4(4):
402-407
DOI: 10.21873/cdp.10339
Prognostic Role of Platelet-to-Lymphocyte and Neutrophil-to-Lymphocyte Ratios in Patients Irradiated for Glioblastoma Multiforme
Cancer Diagnosis & Prognosis
Jul-Aug;
4(4):
408-415
DOI: 10.21873/cdp.10340
BMP Signaling Is a Prognostic Marker in Patients With Colorectal Cancer and Associates With Frailty
Cancer Diagnosis & Prognosis
Jul-Aug;
4(4):
416-423
DOI: 10.21873/cdp.10341
Laryngeal Preservation Rate and Salvage Therapy Following Initial Recurrence in a Real-world Setting After Definitive Radiation Therapy in Patients With Locally Advanced Laryngeal Squamous Cell Carcinoma
Cancer Diagnosis & Prognosis
Jul-Aug;
4(4):
424-429
DOI: 10.21873/cdp.10342
Colposcopically Directed Biopsy Before Ablative Treatment Versus Direct Ablative Treatment in Patients With Cervical Oncogenic HPV
Cancer Diagnosis & Prognosis
Jul-Aug;
4(4):
430-433
DOI: 10.21873/cdp.10343
Tubular Carcinoma of the Breast: The Possibility to Omit Sentinel Lymph Node Biopsy
Cancer Diagnosis & Prognosis
Jul-Aug;
4(4):
434-440
DOI: 10.21873/cdp.10344
Gleason Pattern 5 May Be a Prognostic Factor in Radium-223 Treatment
Cancer Diagnosis & Prognosis
Jul-Aug;
4(4):
441-446
DOI: 10.21873/cdp.10345
Age Is a Risk Factor for Olaparib Dose Modification and Discontinuation in Patients With Ovarian Cancer
Cancer Diagnosis & Prognosis
Jul-Aug;
4(4):
447-453
DOI: 10.21873/cdp.10346
Successful Management of Upper Gastrointestinal Obstruction With Primary Advanced Ovarian Cancer
Cancer Diagnosis & Prognosis
Jul-Aug;
4(4):
454-458
DOI: 10.21873/cdp.10347
Effects of Chemotherapy and Radiation Therapy on Early Laryngeal Cancers
Cancer Diagnosis & Prognosis
Jul-Aug;
4(4):
459-463
DOI: 10.21873/cdp.10348
Attempt to Substitute the Oncotype DX Breast Recurrence Score® Test by Histopathological Factors and MUC1 Protein Expression
Cancer Diagnosis & Prognosis
Jul-Aug;
4(4):
464-469
DOI: 10.21873/cdp.10349
Radiotherapy for Solitary Bony or Extramedullary Plasmacytoma
Cancer Diagnosis & Prognosis
Jul-Aug;
4(4):
470-474
DOI: 10.21873/cdp.10350
Cachexia Index Is a Prognostic Indicator in Patients With Metastatic Urothelial Carcinoma Treated With Systemic Chemotherapy
Cancer Diagnosis & Prognosis
Jul-Aug;
4(4):
475-481
DOI: 10.21873/cdp.10351
Geriatric Nutritional Risk Index as Prognostic Marker for Elderly Patients With Small Cell Lung Cancer
Cancer Diagnosis & Prognosis
Jul-Aug;
4(4):
482-488
DOI: 10.21873/cdp.10352
Global Immune-Nutrition-Information Index Is Independent Prognostic Factor for Gastric Cancer Patients Who Received Curative Treatment
Cancer Diagnosis & Prognosis
Jul-Aug;
4(4):
489-495
DOI: 10.21873/cdp.10353
Prognostic Impact of the Administration of Antibiotics and Proton Pump Inhibitors in Immune Checkpoint Inhibitor Combination Therapy for Advanced Renal Cell Carcinoma
Cancer Diagnosis & Prognosis
Jul-Aug;
4(4):
496-502
DOI: 10.21873/cdp.10354
Nutritional Status Is Associated With Physical Improvement of Palliative Cancer Patients During Cancer Rehabilitation
Cancer Diagnosis & Prognosis
Jul-Aug;
4(4):
503-509
DOI: 10.21873/cdp.10355
Impact of Circular Stapler Size on the Risk of Anastomotic Complications in Patients With Left-sided Colorectal Cancer: A Propensity Score-matched Study
Cancer Diagnosis & Prognosis
Jul-Aug;
4(4):
510-514
DOI: 10.21873/cdp.10356
Comparing the Effectiveness of Afatinib and Osimertinib for Patients With PD-L1-positive EGFR-mutant Non-small Cell Carcinoma
Cancer Diagnosis & Prognosis
Jul-Aug;
4(4):
515-520
DOI: 10.21873/cdp.10357
Comprehensive Analysis of Craniopharyngioma: Epidemiology, Clinical Characteristics, Management Strategies, and Role of Radiotherapy
Cancer Diagnosis & Prognosis
Jul-Aug;
4(4):
521-528
DOI: 10.21873/cdp.10358
Therapeutic Resistance in G-CSF Producing Lung Cancer With EGFR Mutation
Cancer Diagnosis & Prognosis
Jul-Aug;
4(4):
529-533
DOI: 10.21873/cdp.10359
Laparoscopic Partial Splenectomy May Be Valuable for the Diagnosis of Malignant Lymphoma: A Case Report
Cancer Diagnosis & Prognosis
Jul-Aug;
4(4):
534-538
DOI: 10.21873/cdp.10360
Multimodal Imaging, Including Laser Speckle Flowgraphy: A Case of Retinal Metastasis
Cancer Diagnosis & Prognosis
Jul-Aug;
4(4):
539-543
DOI: 10.21873/cdp.10361
Review articles
The Role of Speedy/RINGO Protein in Breast Cancer as a Future Biomarker
Cancer Diagnosis & Prognosis
May-June;
4(3):
209-213
DOI: 10.21873/cdp.10310
Transforming 'Junk' DNA into Cancer Warriors: The Role of Pseudogenes in Hepatocellular Carcinoma
Cancer Diagnosis & Prognosis
May-June;
4(3):
214-222
DOI: 10.21873/cdp.10311
Investigating the Difference in Quality of Life Between Immediate and Delayed Breast Cancer Reconstruction: A Systematic Review
Cancer Diagnosis & Prognosis
May-June;
4(3):
223-230
DOI: 10.21873/cdp.10312
Expression of DNA Repair Genes in Ewing Sarcoma
Cancer Diagnosis & Prognosis
May-June;
4(3):
231-238
DOI: 10.21873/cdp.10313
Efficacy of Recombinant Methioninase on Late-stage Patient Cancer in the Histoculture Drug Response Assay (HDRA) as a Potential Functional Biomarker of Sensitivity to Methionine-restriction Therapy in the Clinic
Cancer Diagnosis & Prognosis
May-June;
4(3):
239-243
DOI: 10.21873/cdp.10314
Research articles
Risk Factors for Adverse Events of Nanoliposomal Irinotecan Plus 5-Fluorouracil and L-leucovorin
Cancer Diagnosis & Prognosis
May-June;
4(3):
244-249
DOI: 10.21873/cdp.10315
Factors Associated With Prescription of Systemic Therapy in Real-world Patients With Metastatic Renal Cell Cancer Managed in a Rural Region
Cancer Diagnosis & Prognosis
May-June;
4(3):
250-255
DOI: 10.21873/cdp.10316
Disparities in Trend of Renal Cell Carcinoma Mortality in the United States
Cancer Diagnosis & Prognosis
May-June;
4(3):
256-263
DOI: 10.21873/cdp.10317
Laparoscopic Colectomy for Cecal Cancer and Intestinal Malrotation: A Case Report
Cancer Diagnosis & Prognosis
May-June;
4(3):
264-269
DOI: 10.21873/cdp.10318
Assessment of Tumor Markers in Renal Transplant Recipients
Cancer Diagnosis & Prognosis
May-June;
4(3):
270-275
DOI: 10.21873/cdp.10319
Postoperative Lymph Node Recurrence in Esophageal Cancer After Surgery and Prognosis of Chemoradiotherapy
Cancer Diagnosis & Prognosis
May-June;
4(3):
276-280
DOI: 10.21873/cdp.10320
The Apparent Diffusion Coefficient of the Paraspinal and Psoas Muscles Are of Prognostic Relevance in Patients With Hepatocellular Carcinoma Undergoing Transarterial Radioembolization
Cancer Diagnosis & Prognosis
May-June;
4(3):
281-287
DOI: 10.21873/cdp.10321
Disparities in Multiple Myeloma Mortality Rate Trends by Demographic Status in the USA
Cancer Diagnosis & Prognosis
May-June;
4(3):
288-294
DOI: 10.21873/cdp.10322
Renal Failure Without Hemodialysis Is a Risk Factor for Postoperative Complications in Colorectal Cancer Surgery
Cancer Diagnosis & Prognosis
May-June;
4(3):
295-300
DOI: 10.21873/cdp.10323
Skeletal Muscle Mass Index Reduction Rate as a Prognostic Indicator for Patients Undergoing Pancreatectomy for Pancreatic Cancer
Cancer Diagnosis & Prognosis
May-June;
4(3):
301-308
DOI: 10.21873/cdp.10324
High Frequency of BRCA2 c.5576_5579del Carriers in Kakogawa, Japan
Cancer Diagnosis & Prognosis
May-June;
4(3):
309-314
DOI: 10.21873/cdp.10325
Dose-escalated Salvage Whole-pelvic Radiotherapy for Biochemical Recurrence After Radical Prostatectomy for High-risk Prostate Cancer
Cancer Diagnosis & Prognosis
May-June;
4(3):
315-319
DOI: 10.21873/cdp.10326
Oxaliplatin-induced Acute Neurotoxicity Recovers Between Repeat Infusion Cycles: An Axonal Excitability Repeated Multiple Measurements Study
Cancer Diagnosis & Prognosis
May-June;
4(3):
320-325
DOI: 10.21873/cdp.10327
Prognostic Evaluation of HER2-positive Early Breast Cancers Using Clinico-pathological Criteria
Cancer Diagnosis & Prognosis
May-June;
4(3):
326-332
DOI: 10.21873/cdp.10328
Radiological Cutoff Values for Diagnosis of Lymph Node Metastasis in Colorectal Cancer With Multilevel Analysis
Cancer Diagnosis & Prognosis
May-June;
4(3):
333-339
DOI: 10.21873/cdp.10329
Clinical, Histopathological, and Immunohistochemical Characteristics of Predictive Biomarkers of Breast Cancer: A Retrospective Study
Cancer Diagnosis & Prognosis
May-June;
4(3):
340-351
DOI: 10.21873/cdp.10330
Comparative Analysis of External and Internal Radiotherapy- Dependent Plans in Patients with Gynecological Cancer
Cancer Diagnosis & Prognosis
May-June;
4(3):
352-358
DOI: 10.21873/cdp.10331
Short-course Radiotherapy for Airway Stenting in Malignant Airway Obstruction: A Case Report and Literature Review
Cancer Diagnosis & Prognosis
May-June;
4(3):
359-362
DOI: 10.21873/cdp.10332
Pleomorphic Rhabdomyosarcoma of the Uterine Corpus in an Adult Who Underwent Multi-gene Panel Testing
Cancer Diagnosis & Prognosis
May-June;
4(3):
363-369
DOI: 10.21873/cdp.10333
Maxillary Sinus NUT Carcinoma: A Case Report
Cancer Diagnosis & Prognosis
May-June;
4(3):
370-378
DOI: 10.21873/cdp.10334
A Rare Inflammatory Myofibroblastic Tumor of the Spleen: A Case Report
Cancer Diagnosis & Prognosis
May-June;
4(3):
379-383
DOI: 10.21873/cdp.10335
First Case Report of Bilateral Parotid Lymphoepithelial Carcinoma
Cancer Diagnosis & Prognosis
May-June;
4(3):
384-389
DOI: 10.21873/cdp.10336
Review article
Programmed Death Ligand 1: Unveiling its Impact on Endometrial Carcinogenesis
Cancer Diagnosis & Prognosis
Mar-Apr;
4(2):
91-96
DOI: 10.21873/cdp.10292
Research articles
NK and T-lymphocyte Kinetics Predict Outcome in Myeloma Patients Treated With Elotuzumab, Lenalidomide Plus Dexamethasone
Cancer Diagnosis & Prognosis
Mar-Apr;
4(2):
97-104
DOI: 10.21873/cdp.10293
Clinical Analysis of Oral Squamous Cell Carcinoma: A Single-institution Experience
Cancer Diagnosis & Prognosis
Mar-Apr;
4(2):
105-110
DOI: 10.21873/cdp.10294
Systemic Chemotherapy for Advanced Hepatocellular Carcinoma in Patients With Child-Pugh class B
Cancer Diagnosis & Prognosis
Mar-Apr;
4(2):
111-116
DOI: 10.21873/cdp.10295
Curative Radiotherapy for Oropharyngeal Squamous Cell Carcinoma Stratified by p16 Status, According to the Eighth Edition American Joint Committee on Cancer Staging Manual: A Retrospective Study
Cancer Diagnosis & Prognosis
Mar-Apr;
4(2):
117-121
DOI: 10.21873/cdp.10296
Evaluation of Atezolizumab Plus Bevacizumab Versus Modified Lenvatinib Therapy in Child-Pugh A Unresectable Hepatocellular Carcinoma
Cancer Diagnosis & Prognosis
Mar-Apr;
4(2):
122-128
DOI: 10.21873/cdp.10297
Comparative Expression Analysis of TP53 Tumor Suppressor and MDM2 Oncogene in Colorectal Adenocarcinoma
Cancer Diagnosis & Prognosis
Mar-Apr;
4(2):
129-134
DOI: 10.21873/cdp.10298
Prognostic Significance of Sarcopenia and Eicosapentaenoic Acid (EPA) Levels in Patients With Unresectable Pancreatic or Biliary Tract Cancer
Cancer Diagnosis & Prognosis
Mar-Apr;
4(2):
135-140
DOI: 10.21873/cdp.10299
Differential Diagnosis of Lipomatous Tumors Using 18F-Fluorodeoxygulcose Positron Emission Tomography/Computed Tomography: A Retrospective Observational Study
Cancer Diagnosis & Prognosis
Mar-Apr;
4(2):
141-146
DOI: 10.21873/cdp.10300
Preoperative Myosteatosis and Prognostic Nutritional Index Predict Survival in Older Patients With Resected Biliary Tract Cancer
Cancer Diagnosis & Prognosis
Mar-Apr;
4(2):
147-156
DOI: 10.21873/cdp.10301
A Multicenter Analysis of Short-term and Long-term Outcomes Following Laparoscopic Multivisceral Resection for Advanced Colorectal Cancer
Cancer Diagnosis & Prognosis
Mar-Apr;
4(2):
157-164
DOI: 10.21873/cdp.10302
FOLFIRINOX or Gemcitabine Plus Nab-paclitaxel as First Line Treatment in Pancreatic Cancer: A Real-World Comparison
Cancer Diagnosis & Prognosis
Mar-Apr;
4(2):
165-171
DOI: 10.21873/cdp.10303
Clinical Outcomes in Patients With DLBCL Treated With R-CHOP According to Radiotherapy and Interim PET Response
Cancer Diagnosis & Prognosis
Mar-Apr;
4(2):
172-181
DOI: 10.21873/cdp.10304
Post-treatment Neutrophil/Lymphocyte Ratio Is a Prognostic Factor in Head and Neck Cancers Treated With Nivolumab
Cancer Diagnosis & Prognosis
Mar-Apr;
4(2):
182-188
DOI: 10.21873/cdp.10305
Gastric Small Cell Neuroendocrine Carcinoma With Loss of Epithelial Markers Expression
Cancer Diagnosis & Prognosis
Mar-Apr;
4(2):
189-192
DOI: 10.21873/cdp.10306
Removal of an Intrauterine Polypoid Lesion Resolved Chemotherapy-resistant Gestational Trophoblastic Neoplasia: A Case Report
Cancer Diagnosis & Prognosis
Mar-Apr;
4(2):
193-197
DOI: 10.21873/cdp.10307
Pseudomyxoma Peritonei: A Challenging Clinical Diagnosis. Case Report and Review of the Literature
Cancer Diagnosis & Prognosis
Mar-Apr;
4(2):
198-203
DOI: 10.21873/cdp.10308
A Case of Aggressive Lung Squamous Cell Carcinoma With Aberrant Cytoplasmic p53 Aggregation
Cancer Diagnosis & Prognosis
Mar-Apr;
4(2):
204-208
DOI: 10.21873/cdp.10309
Review articles
Assessing Radiological Response to Immunotherapy in Lung Cancer: An Evolving Arena
Cancer Diagnosis & Prognosis
Jan-Feb;
4(1):
1-8
DOI: 10.21873/cdp.10278
Development and Clinical Applications of PI3K/AKT/mTOR Pathway Inhibitors as a Therapeutic Option for Leukemias
Cancer Diagnosis & Prognosis
Jan-Feb;
4(1):
9-24
DOI: 10.21873/cdp.10279
PTEN Deregulation Mechanisms in Salivary Gland Carcinomas
Cancer Diagnosis & Prognosis
Jan-Feb;
4(1):
25-29
DOI: 10.21873/cdp.10280
Research articles
Precise Non-invasive Imaging Mouse Model of Pancreatic Cancer: Very Narrow Band-width Laser Fluorescence Excitation of Green Fluorescent Protein Provides Ultra-bright Tumor Images With no Skin Autofluorescence
Cancer Diagnosis & Prognosis
Jan-Feb;
4(1):
30-33
DOI: 10.21873/cdp.10281
Neutrophil-to-Lymphocyte Ratio Predicts Immune-related Adverse Events in Patients With Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab
Cancer Diagnosis & Prognosis
Jan-Feb;
4(1):
34-41
DOI: 10.21873/cdp.10282
Prevalence of Multiple High Risk Human Papilloma Virus (HR-HPV) Infections in Cervical Cancer Screening in Lazio Region, Italy
Cancer Diagnosis & Prognosis
Jan-Feb;
4(1):
42-45
DOI: 10.21873/cdp.10283
Survival Following Palliative Radiotherapy for Head and Neck Squamous Cell Carcinoma: Examining Treatment Indications in Elderly Patients
Cancer Diagnosis & Prognosis
Jan-Feb;
4(1):
46-50
DOI: 10.21873/cdp.10284
Significance of Preoperative Tooth Loss in Patients Who Underwent Gastrectomy for Gastric Cancer
Cancer Diagnosis & Prognosis
Jan-Feb;
4(1):
51-56
DOI: 10.21873/cdp.10285
Factors Involved in Shared Decision-making Regarding Treatment Selection by Patients With Cancer
Cancer Diagnosis & Prognosis
Jan-Feb;
4(1):
57-65
DOI: 10.21873/cdp.10286
Percutaneous Perirenal Mass Biopsy in a Sitting Position Revealed Extramedullary Relapse of Acute Lymphoblastic Leukemia
Cancer Diagnosis & Prognosis
Jan-Feb;
4(1):
66-70
DOI: 10.21873/cdp.10287
Bipolar Head Perforation With Rhabdomyosarcoma of the Thigh: A Case Report With Literature Review
Cancer Diagnosis & Prognosis
Jan-Feb;
4(1):
71-76
DOI: 10.21873/cdp.10288
Long-term Survival in a Patient With Transformation of Waldenström’s Macroglobulinemia into DLBCL
Cancer Diagnosis & Prognosis
Jan-Feb;
4(1):
77-80
DOI: 10.21873/cdp.10289
Three Dimensional (3D) Laparoscopic Nephron-sparing Treatment of a Huge Cystic Nephroma: A Case Report and Literature Review
Cancer Diagnosis & Prognosis
Jan-Feb;
4(1):
81-84
DOI: 10.21873/cdp.10290
Two Cases of Emergency Tracheostomy After Head and Neck Photoimmunotherapy
Cancer Diagnosis & Prognosis
Jan-Feb;
4(1):
85-90
DOI: 10.21873/cdp.10291
Review articles
An Overview of Renal Cell Carcinoma Hallmarks, Drug Resistance, and Adjuvant Therapies
Cancer Diagnosis & Prognosis
Nov-Dec;
3(6):
616-634
DOI: 10.21873/cdp.10264
Heat Shock Proteins’ Expression Profiles in Odontogenic Ameloblastomas and Cysts
Cancer Diagnosis & Prognosis
Nov-Dec;
3(6):
635-638
DOI: 10.21873/cdp.10265
The Role of γH2AX in Replication Stress-induced Carcinogenesis: Possible Links and Recent Developments
Cancer Diagnosis & Prognosis
Nov-Dec;
3(6):
639-648
DOI: 10.21873/cdp.10266
Research articles
Recombinant-methioninase-producing Escherichia coli Instilled in the Microbiome Inhibits Triple-negative Breast Cancer in an Orthotopic Cell-line Mouse Model
Cancer Diagnosis & Prognosis
Nov-Dec;
3(6):
649-654
DOI: 10.21873/cdp.10267
Recombinant Methioninase Lowers the Effective Dose of Regorafenib Against Colon-Cancer Cells: A Strategy for Widespread Clinical Use of a Toxic Drug
Cancer Diagnosis & Prognosis
Nov-Dec;
3(6):
655-659
DOI: 10.21873/cdp.10268
Combined Ultrasound and Computed Tomography Guidance in Radiofrequency Ablation for Hepatocellular Carcinoma Reduces Local Recurrence Rate
Cancer Diagnosis & Prognosis
Nov-Dec;
3(6):
660-666
DOI: 10.21873/cdp.10269
Preoperative Hemoglobin Level as Predictor of the Development of High-output Stoma in Rectal Cancer Surgery
Cancer Diagnosis & Prognosis
Nov-Dec;
3(6):
667-672
DOI: 10.21873/cdp.10270
Staging for Breast Cancer: A Comparison Between Old and New Approaches
Cancer Diagnosis & Prognosis
Nov-Dec;
3(6):
673-677
DOI: 10.21873/cdp.10271
The Impact of Being Underweight on the Prognosis of Older Patients With Early Breast Cancer
Cancer Diagnosis & Prognosis
Nov-Dec;
3(6):
678-686
DOI: 10.21873/cdp.10272
Preoperative Frailty Assessed Comprehensively by a Questionnaire Predicts a Poor Survival Following Curative Resection of Gastric Cancer
Cancer Diagnosis & Prognosis
Nov-Dec;
3(6):
687-694
DOI: 10.21873/cdp.10273
Expression Pattern of Tumor-associated Antigens in Neuroblastoma: Association With Cytogenetic Features and Survival
Cancer Diagnosis & Prognosis
Nov-Dec;
3(6):
695-705
DOI: 10.21873/cdp.10274
Pretreatment PLR Is Preferable to NLR and LMR as a Predictor in Locally Advanced and Metastatic Bladder Cancer
Cancer Diagnosis & Prognosis
Nov-Dec;
3(6):
706-715
DOI: 10.21873/cdp.10275
Impact of COVID-19 Pandemic on Advanced Non-small Cell Lung Cancer Treatment at a Japanese Hospital
Cancer Diagnosis & Prognosis
Nov-Dec;
3(6):
716-720
DOI: 10.21873/cdp.10276
Thirty-day Mortality in Palliative Radiotherapy: A Retrospective Cohort Analysis in a Single Center
Cancer Diagnosis & Prognosis
Nov-Dec;
3(6):
721-725
DOI: 10.21873/cdp.10277
Review article
Impact of Amplified Oncogenes on Salivary Gland Carcinomas
Cancer Diagnosis & Prognosis
Sep-Oct;
3(5):
528-532
DOI: 10.21873/cdp.10250
Research articles
The Number of Colon Crypts in Digital Mucosal Samples: A New Independent Parameter for Diagnosing Ulcerative Colitis
Cancer Diagnosis & Prognosis
Sep-Oct;
3(5):
533-537
DOI: 10.21873/cdp.10251
Bone Metastases in Renal Cell Carcinoma: Impact of Immunotherapy on Survival
Cancer Diagnosis & Prognosis
Sep-Oct;
3(5):
538-542
DOI: 10.21873/cdp.10252
A Novel Observational Strategy for Nonfunctional Pancreatic Neuroendocrine Neoplasms With Texture Analysis: A Multicenter Retrospective Study
Cancer Diagnosis & Prognosis
Sep-Oct;
3(5):
543-550
DOI: 10.21873/cdp.10253
Circulating Plasma Cell-free DNA (cfDNA) as a Predictive Biomarker for Radiotherapy: Results from a Prospective Trial in Head and Neck Cancer
Cancer Diagnosis & Prognosis
Sep-Oct;
3(5):
551-557
DOI: 10.21873/cdp.10254
Breast Cancers Secreting Sialyl-fibronectin Are Less Likely to Cause Epithelial-mesenchymal Transition and Have Good Prognoses
Cancer Diagnosis & Prognosis
Sep-Oct;
3(5):
558-570
DOI: 10.21873/cdp.10255
Optimal Timing of Laparoscopic Cholecystectomy After Conservative Therapy for Acute Cholecystitis
Cancer Diagnosis & Prognosis
Sep-Oct;
3(5):
571-576
DOI: 10.21873/cdp.10256
Distress Scores During Radiotherapy for Lung Cancer: Course and Prognostic Factors
Cancer Diagnosis & Prognosis
Sep-Oct;
3(5):
577-581
DOI: 10.21873/cdp.10257
Is 6 Months the Optimal Duration of Adjuvant Chemotherapy for Pancreatic Cancer?
Cancer Diagnosis & Prognosis
Sep-Oct;
3(5):
582-589
DOI: 10.21873/cdp.10258
Multiple Bone Cysts Caused by Hyperparathyroidism: A Case Report and Review of the Literature
Cancer Diagnosis & Prognosis
Sep-Oct;
3(5):
590-596
DOI: 10.21873/cdp.10259
Surgery for Rectal Cancer With Mixed Reality of 3D Model During Operation: A Case Report
Cancer Diagnosis & Prognosis
Sep-Oct;
3(5):
597-600
DOI: 10.21873/cdp.10260
Septic Cervicofacial Phlegmon Following Basal Cell Carcinoma Excision: Life-threatening Complication of Routine Operation in Maxillofacial Surgery?
Cancer Diagnosis & Prognosis
Sep-Oct;
3(5):
601-604
DOI: 10.21873/cdp.10261
BRAF Mutation Heterogeneity Detected Using Circulating Tumor DNA Sequencing in Synchronous Colon Cancer: A Case Report
Cancer Diagnosis & Prognosis
Sep-Oct;
3(5):
605-608
DOI: 10.21873/cdp.10262
A Novel Esophagogastrostomy Technique for Laparoscopic Proximal Gastrectomy: Conical Remnant Gastroesophageal Side-overlap Fundoplication
Cancer Diagnosis & Prognosis
Sep-Oct;
3(5):
609-615
DOI: 10.21873/cdp.10263
Review articles
Using Liquid Biopsy to Predict Relapse After Radiotherapy in Squamous Cell Head-Neck and Esophageal Cancer
Cancer Diagnosis & Prognosis
Jul-Aug;
3(4):
403-410
DOI: 10.21873/cdp.10232
Mutational Signatures in Salivary Gland Carcinomas
Cancer Diagnosis & Prognosis
Jul-Aug;
3(4):
411-415
DOI: 10.21873/cdp.10233
Research articles
Bioinformatics Analysis of Immune Infiltration In Endometrial Carcinoma Tumors and its Relationship With Prognosis
Cancer Diagnosis & Prognosis
Jul-Aug;
3(4):
416-427
DOI: 10.21873/cdp.10234
Increased KCNN4 Expression Is Correlated With Poor Survival in Lower Grade Glioma
Cancer Diagnosis & Prognosis
Jul-Aug;
3(4):
428-432
DOI: 10.21873/cdp.10235
Interobserver Variability in Contouring Hepatocellular Carcinoma at a Tertiary Center
Cancer Diagnosis & Prognosis
Jul-Aug;
3(4):
433-438
DOI: 10.21873/cdp.10236
High SLC20A1 Expression Indicates Poor Prognosis in Prostate Cancer
Cancer Diagnosis & Prognosis
Jul-Aug;
3(4):
439-448
DOI: 10.21873/cdp.10237
Spinal Instability as a Prognostic Factor in Patients With Spinal Metastasis of Castration-resistant Prostate Cancer
Cancer Diagnosis & Prognosis
Jul-Aug;
3(4):
449-456
DOI: 10.21873/cdp.10238
WPOI-4/5 Correlates With Lymph Node Recurrence and Poor Prognosis in Early-stage Tongue Squamous Cell Carcinoma
Cancer Diagnosis & Prognosis
Jul-Aug;
3(4):
457-462
DOI: 10.21873/cdp.10239
Endometrioid Carcinoma of the Uterine Corpus With a Micropapillary Component: A Novel Prognostic Factor For Metastasis
Cancer Diagnosis & Prognosis
Jul-Aug;
3(4):
463-467
DOI: 10.21873/cdp.10240
An Imaging Feature Predicts Efficacy of Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Cancer Diagnosis & Prognosis
Jul-Aug;
3(4):
468-474
DOI: 10.21873/cdp.10241
A Case of Tracheoesophageal Fistula in a Non-metastatic Site During Lenvatinib Treatment for Hepatocellular Carcinoma
Cancer Diagnosis & Prognosis
Jul-Aug;
3(4):
475-478
DOI: 10.21873/cdp.10242
Avoiding Dosimetric Risk Factors for Complications in Neoadjuvant Chemoradiotherapy for Lung Cancer: Conventional Radiotherapy Versus Intensity-modulated Radiotherapy
Cancer Diagnosis & Prognosis
Jul-Aug;
3(4):
479-483
DOI: 10.21873/cdp.10243
Prognosis of Patients Receiving Chemotherapy for Metastatic Upper Tract Urothelial Carcinoma Compared With Metastatic Urinary Bladder Cancer
Cancer Diagnosis & Prognosis
Jul-Aug;
3(4):
484-490
DOI: 10.21873/cdp.10244
A Prospective Study of Intensity-modulated Radiation Therapy Using a Standard Radiation Dose for High-grade Glioma
Cancer Diagnosis & Prognosis
Jul-Aug;
3(4):
491-497
DOI: 10.21873/cdp.10245
Hypothyroidism With ACTH Deficiency During Pembrolizumab Therapy for Lung Cancer: Case Report and Literature Review
Cancer Diagnosis & Prognosis
Jul-Aug;
3(4):
498-503
DOI: 10.21873/cdp.10246
Comparison of Selected Older and Younger Patients Regarding Optimal Surgical Treatment of Colorectal Cancer: A Prospective Cohort Study
Cancer Diagnosis & Prognosis
Jul-Aug;
3(4):
504-513
DOI: 10.21873/cdp.10247
Feasibility and Safety of Super Energy-dense Oral Nutritional Supplementation in Postoperative Gastric Cancer Patients
Cancer Diagnosis & Prognosis
Jul-Aug;
3(4):
514-521
DOI: 10.21873/cdp.10248
A Case Report of Aggressive Fumarate Hydrase-deficient Renal Cell Carcinoma With Loss of HLA Antigens
Cancer Diagnosis & Prognosis
Jul-Aug;
3(4):
522-527
DOI: 10.21873/cdp.10249
Review articles
Synergy of Combining Methionine Restriction and Chemotherapy: The Disruptive Next Generation of Cancer Treatment
Cancer Diagnosis & Prognosis
May-June;
3(3):
272-281
DOI: 10.21873/cdp.10212
Spindle Cell Lipoma and Pleomorphic Lipoma: An Update and Review
Cancer Diagnosis & Prognosis
May-June;
3(3):
282-290
DOI: 10.21873/cdp.10213
Association Between ERG/PTEN Genes and Pathologic Parameters of Prostate Cancer With an Emphasis on Gleason Score: A Literature Review
Cancer Diagnosis & Prognosis
May-June;
3(3):
291-296
DOI: 10.21873/cdp.10214
Calpain-mediated Mechanoptosis in Breast Adenocarcinoma
Cancer Diagnosis & Prognosis
May-June;
3(3):
297-301
DOI: 10.21873/cdp.10215
Research articles
Results of a Phase II Trial Testing the Resensitization With Trabectedin in Platinum-resistant Ovarian Cancer
Cancer Diagnosis & Prognosis
May-June;
3(3):
302-310
DOI: 10.21873/cdp.10216
Clinicopathological and Prognostic Relevance of Tumoral Suppression of Tumorigenicity 2 Expression in Patients With Surgically Resected Pancreatic Carcinoma
Cancer Diagnosis & Prognosis
May-June;
3(3):
311-319
DOI: 10.21873/cdp.10217
Pre-treatment Emotional Distress in Patients Receiving Radiotherapy for Gynecologic Cancers
Cancer Diagnosis & Prognosis
May-June;
3(3):
320-326
DOI: 10.21873/cdp.10218
Prognostic Significance of Immune-related Adverse Events in Metastatic Renal Cell Carcinoma Patients Treated With Immune-checkpoint-inhibitors
Cancer Diagnosis & Prognosis
May-June;
3(3):
327-333
DOI: 10.21873/cdp.10219
Is the Routine Histopathologic Diagnosis of Ulcerative Colitis Based on Cross-cut Sections or on Well-oriented Sections?
Cancer Diagnosis & Prognosis
May-June;
3(3):
334-337
DOI: 10.21873/cdp.10220
Prognostic Value of Peritoneal Lavage Cytology in Potentially Resectable Pancreatic Cancer Stratified by Cytologic Status
Cancer Diagnosis & Prognosis
May-June;
3(3):
338-346
DOI: 10.21873/cdp.10221
The Usefulness of Total Laryngectomy in Sarcopenic Patients With Hypopharyngeal and Laryngeal Cancer
Cancer Diagnosis & Prognosis
May-June;
3(3):
347-353
DOI: 10.21873/cdp.10222
Significance of the Prognostic Immune and Nutritional Index in Patients With Stage I-III Colorectal Cancer
Cancer Diagnosis & Prognosis
May-June;
3(3):
354-359
DOI: 10.21873/cdp.10223
Clinical Features of Borderline Ovarian Seromucinous Tumor
Cancer Diagnosis & Prognosis
May-June;
3(3):
360-364
DOI: 10.21873/cdp.10224
V5 and High Sensitivity Cardiac Troponin T for Early Detection of Cardiac Toxicity During Left Breast Cancer Irradiation
Cancer Diagnosis & Prognosis
May-June;
3(3):
365-369
DOI: 10.21873/cdp.10225
Optimal Time Point for Evaluation of Response to Pembrolizumab Treatment in Japanese Patients With Metastatic Urothelial Carcinoma
Cancer Diagnosis & Prognosis
May-June;
3(3):
370-376
DOI: 10.21873/cdp.10226
Long-term Progression-free Survival With Pemetrexed Plus Bevacizumab in NSCLC Patients
Cancer Diagnosis & Prognosis
May-June;
3(3):
377-382
DOI: 10.21873/cdp.10227
Successful Phytotherapy for Acute Refractory Radiation Cystitis in a Cervical Cancer Patient: A Case Report
Cancer Diagnosis & Prognosis
May-June;
3(3):
383-386
DOI: 10.21873/cdp.10228
Successful Retreatment of Metastatic Triple-negative Breast Cancer With Immune Checkpoint Inhibitors and Chemotherapy
Cancer Diagnosis & Prognosis
May-June;
3(3):
387-391
DOI: 10.21873/cdp.10229
Experience With J-Plasma Device in Achieving Complete Cytoreduction in Patients With Ovarian Cancer
Cancer Diagnosis & Prognosis
May-June;
3(3):
392-397
DOI: 10.21873/cdp.10230
Predicted Configuration and Stability of the ATAD2/SOX10 Complex Using Molecular Dynamics Simulations
Cancer Diagnosis & Prognosis
May-June;
3(3):
398-402
DOI: 10.21873/cdp.10231
Review articles
Primary Testicular Lymphoma: Single Center Experience
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
139-144
DOI: 10.21873/cdp.10192
An Update on Clinicopathological, Imaging, and Genetic Features of Angioleiomyoma
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
145-150
DOI: 10.21873/cdp.10193
Anti-EGFR/BRAF-Tyrosine Kinase Inhibitors in Thyroid Carcinoma
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
151-156
DOI: 10.21873/cdp.10194
Metachronous Single Pulmonary Metastasis of Prostate Cancer: Report of a Rare Case and Literature Review
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
157-162
DOI: 10.21873/cdp.10195
Iron Deficiency Anemia in Colorectal Cancer Patients: Is Preoperative Intravenous Iron Infusion Indicated? A Narrative Review of the Literature
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
163-168
DOI: 10.21873/cdp.10196
DNA Mismatch Repair System Imbalances in Breast Adenocarcinoma
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
169-174
DOI: 10.21873/cdp.10197
Research articles
Pharmacodynamic Modeling Identifies Synergistic Interaction Between Chloroquine and Trastuzumab in Refractory HER2- positive Breast Cancer Cells
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
175-182
DOI: 10.21873/cdp.10198
Effects of siRNA-mediated Silencing of ERBB2, IGF-1R, and ITGB1 in HER2-positive Breast Cancer Cells
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
183-188
DOI: 10.21873/cdp.10199
Impact of CD34-dependent Micro Vessel Density on Periapical Odontogenic Cysts
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
189-193
DOI: 10.21873/cdp.10200
Clinical Outcomes and Toxicity of CT-guided High Dose-rate Brachytherapy in Women With Locally-advanced Cervical Cancer
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
194-200
DOI: 10.21873/cdp.10201
Clinical Outcomes of Stereotactic Body Radiation Therapy for Early-stage Non-small Cell Lung Cancer
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
201-207
DOI: 10.21873/cdp.10202
Perineural Invasion Predicts Unfavorable Prognosis in Patients With Invasive Breast Cancer
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
208-214
DOI: 10.21873/cdp.10203
NSCLC Patients Achieving Long-term Progression-free Survival With Docetaxel Plus Ramucirumab: A Retrospective Study
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
215-220
DOI: 10.21873/cdp.10204
Long-term Prognostic Impact of Metachronous Rectal Cancer in Patients With Familial Adenomatous Polyposis: A Single-center Retrospective Study
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
221-229
DOI: 10.21873/cdp.10205
Pretreatment Hemoglobin Levels and Platelet-to-Lymphocyte Ratio Predict Survival Benefit from Pembrolizumab in Advanced Urothelial Carcinoma
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
230-235
DOI: 10.21873/cdp.10206
Does Pathological T-Factor Affect Long-term Prognosis of Locally Advanced Colorectal Cancer Treated With Laparoscopic Multivisceral Resection?
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
236-243
DOI: 10.21873/cdp.10207
Discontinuation of Immune Checkpoint Inhibitor due to irAEs in NSCLC Patients With EGFR Mutation
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
244-250
DOI: 10.21873/cdp.10208
Refusal of Subsequent Treatment in Patients With EGFR-mutant Non-small-cell Lung Cancer After Response to EGFR-TKIs
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
251-256
DOI: 10.21873/cdp.10209
Palliative Radiotherapy Induced Severe Tumor Lysis Syndrome in a Patient With Multiple Myeloma With Skin Involvement: A Case Report and Review of Literature
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
257-263
DOI: 10.21873/cdp.10210
Real-world Data of Paclitaxel and Cetuximab in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
264-271
DOI: 10.21873/cdp.10211
Review articles
The Rationality of Implementation of Dimethyl Sulfoxide as Differentiation-inducing Agent in Cancer Therapy
Cancer Diagnosis & Prognosis
Jan-Feb;
3(1):
1-8
DOI: 10.21873/cdp.10172
Indications, Safety, Efficacy and Survival Benefit of Intraperitoneal Chemotherapy in Patients With Advanced Gastric Cancer
Cancer Diagnosis & Prognosis
Jan-Feb;
3(1):
9-16
DOI: 10.21873/cdp.10173
Involvement of the PRL-PAK1 Pathway in Cancer Cell Migration
Cancer Diagnosis & Prognosis
Jan-Feb;
3(1):
17-25
DOI: 10.21873/cdp.10174
The Landscape of Single Nucleotide Polymorphisms in Papillary Thyroid Carcinoma
Cancer Diagnosis & Prognosis
Jan-Feb;
3(1):
26-30
DOI: 10.21873/cdp.10175
Research articles
Prognostic Role of Preoperative D-dimer Levels in Patients With Stage I-III Colorectal Cancer
Cancer Diagnosis & Prognosis
Jan-Feb;
3(1):
38-43
DOI: 10.21873/cdp.10177
Neutrophil-to-Lymphocyte Ratio Is a Major Prognostic Factor in Non-small Cell Lung Carcinoma Patients Undergoing First Line Immunotherapy With Pembrolizumab
Cancer Diagnosis & Prognosis
Jan-Feb;
3(1):
44-52
DOI: 10.21873/cdp.10178
Relationship Between TTF-1 Expression and PFS of Pemetrexed-containing Chemotherapy in Non-squamous-NSCLC Patients With and Without Driver Genes
Cancer Diagnosis & Prognosis
Jan-Feb;
3(1):
53-60
DOI: 10.21873/cdp.10179
A Retrospective Study of Patients Undergoing Palliative Radiotherapy for Airway Obstruction due to Lung Cancer
Cancer Diagnosis & Prognosis
Jan-Feb;
3(1):
61-66
DOI: 10.21873/cdp.10180
Skeletal Muscle Loss During Neoadjuvant Chemotherapy Predicts the Incidence of Postoperative Infectious Complications in Esophageal Cancer Patients Undergoing Esophagectomy
Cancer Diagnosis & Prognosis
Jan-Feb;
3(1):
67-74
DOI: 10.21873/cdp.10181
Serum Sialyl Fibronectin Is an Indicator of Good Prognosis in Thyroid Cancer
Cancer Diagnosis & Prognosis
Jan-Feb;
3(1):
75-84
DOI: 10.21873/cdp.10182
Clinical Outcomes of Definitive Chemoradiotherapy for Cervical Esophageal Cancer
Cancer Diagnosis & Prognosis
Jan-Feb;
3(1):
85-90
DOI: 10.21873/cdp.10183
Predictors of Adverse Gastrointestinal Events After Stereotactic Body Radiation Therapy for Liver Tumors
Cancer Diagnosis & Prognosis
Jan-Feb;
3(1):
91-95
DOI: 10.21873/cdp.10184
Prognostic Factors of Cervical Adenocarcinoma With Positive Pelvic Lymph Node Metastases Without Preoperative Lymph Node Enlargement Treated With Radical Hysterectomy
Cancer Diagnosis & Prognosis
Jan-Feb;
3(1):
96-101
DOI: 10.21873/cdp.10185
Case reports
Intravascular Lymphoma – The Creepy Crawler: A Case Series and Brief Literature Review
Cancer Diagnosis & Prognosis
Jan-Feb;
3(1):
31-37
DOI: 10.21873/cdp.10176
Incidental Gastric Langerhans Cell Histiocytosis and Synchronous Adenocarcinoma of the Colon: An Interesting Case Report and Literature Review
Cancer Diagnosis & Prognosis
Jan-Feb;
3(1):
102-106
DOI: 10.21873/cdp.10186
Metastasis of a Solitary Fibrous Tumor in the Mandible: A Case Report
Cancer Diagnosis & Prognosis
Jan-Feb;
3(1):
107-114
DOI: 10.21873/cdp.10187
Time to Onset of Gemcitabine-induced Thrombotic Microangiopathy in a Japanese Population: A Case Series and Large-scale Pharmacovigilance Analysis
Cancer Diagnosis & Prognosis
Jan-Feb;
3(1):
115-123
DOI: 10.21873/cdp.10188
Pathological Complete Response to Preoperative Nivolumab Plus Cabozantinib for Renal Cell Carcinoma With Inferior Vena Cava Thrombus: A Case Report
Cancer Diagnosis & Prognosis
Jan-Feb;
3(1):
124-129
DOI: 10.21873/cdp.10189
A Case of Intraocular Metastasis of Lung Cancer Diagnosed Using Cell Block Preparation of the Vitreous Humor
Cancer Diagnosis & Prognosis
Jan-Feb;
3(1):
130-134
DOI: 10.21873/cdp.10190
Pancreatoduodenectomy En Bloc With Superior Mesenteric Artery Resection for Borderline Resectable Pancreatic Cancer – A Case Report and Literature Review
Cancer Diagnosis & Prognosis
Jan-Feb;
3(1):
135-138
DOI: 10.21873/cdp.10191
Review articles
Epigenetic Mechanisms in Breast Adenocarcinoma: Novel DNA Methylation Patterns
Cancer Diagnosis & Prognosis
Nov-Dec;
2(6):
603-608
DOI: 10.21873/cdp.10149
Limited Cerebral Metastases in NSCLC: A Literature Review of SRS Versus Whole-brain Radiotherapy
Cancer Diagnosis & Prognosis
Nov-Dec;
2(6):
609-619
DOI: 10.21873/cdp.10150
Research articles
Examination of the Effect of Proton Pump Inhibitors on the Anticancer Activity of Oxaliplatin
Cancer Diagnosis & Prognosis
Nov-Dec;
2(6):
620-626
DOI: 10.21873/cdp.10151
Prognostic Value of the Perioperative Systemic Inflammation Score for Patients With Curatively Resected Gastric Cancer
Cancer Diagnosis & Prognosis
Nov-Dec;
2(6):
627-633
DOI: 10.21873/cdp.10152
Efficacy and Safety of External-beam Radiation Therapy for Unresectable Primary or Local Recurrent Cholangiocarcinoma
Cancer Diagnosis & Prognosis
Nov-Dec;
2(6):
634-640
DOI: 10.21873/cdp.10153
Tumor Depth Prediction of Gastric Cancer With a T4 Score
Cancer Diagnosis & Prognosis
Nov-Dec;
2(6):
641-647
DOI: 10.21873/cdp.10154
Comparison of Late Toxicity After Whole-pelvis Versus Prostate-only VMAT for Prostate Cancer
Cancer Diagnosis & Prognosis
Nov-Dec;
2(6):
648-653
DOI: 10.21873/cdp.10155
Malignant Peritoneal Mesothelioma Features Shown by FDG-PET/CT
Cancer Diagnosis & Prognosis
Nov-Dec;
2(6):
654-660
DOI: 10.21873/cdp.10156
CAIX Immunostaining in Non-neoplastic Renal Diseases
Cancer Diagnosis & Prognosis
Nov-Dec;
2(6):
661-667
DOI: 10.21873/cdp.10157
Novel Mathematical Diagnostic Analysis of Malignant Biliary Stenosis Using Magnetic Resonance Cholangiography in Patients Undergoing Pancreaticoduodenectomy
Cancer Diagnosis & Prognosis
Nov-Dec;
2(6):
668-680
DOI: 10.21873/cdp.10158
Prognostic Factors for Survival in Patients With High-grade Chondrosarcoma
Cancer Diagnosis & Prognosis
Nov-Dec;
2(6):
681-685
DOI: 10.21873/cdp.10159
Changes in Renal Function of Patients With Prostate Cancer: Focus on Androgen Deprivation Therapy
Cancer Diagnosis & Prognosis
Nov-Dec;
2(6):
686-690
DOI: 10.21873/cdp.10160
Preliminary Evaluation of a Novel Artificial Intelligence-based Prediction Model for Surgical Site Infection in Colon Cancer
Cancer Diagnosis & Prognosis
Nov-Dec;
2(6):
691-696
DOI: 10.21873/cdp.10161
A Single-site Interventional Study on the Contemporary Relevance of Braun Enteroenterostomy After Pancreaticoduodenectomy
Cancer Diagnosis & Prognosis
Nov-Dec;
2(6):
697-701
DOI: 10.21873/cdp.10162
Palliative Radiation Therapy for Intramedullary Spinal Cord Metastasis
Cancer Diagnosis & Prognosis
Nov-Dec;
2(6):
702-706
DOI: 10.21873/cdp.10163
Effect of Aromatase Inhibitors on Serum Calprotectin Levels in an Animal Experimental Model: Trial
Cancer Diagnosis & Prognosis
Nov-Dec;
2(6):
720-730
DOI: 10.21873/cdp.10167
Breast Cancer Sera Changes in Alu Element Methylation Predict Metastatic Disease Progression
Cancer Diagnosis & Prognosis
Nov-Dec;
2(6):
731-738
DOI: 10.21873/cdp.10168
Circulating miRNA Expression Profiling in Breast Cancer Molecular Subtypes: Applying Machine Learning Analysis in Bioinformatics
Cancer Diagnosis & Prognosis
Nov-Dec;
2(6):
739-749
DOI: 10.21873/cdp.10169
Fourier Transform Infrared Spectroscopy in the Study of Discrimination of Lobular Breast Cancers
Cancer Diagnosis & Prognosis
Nov-Dec;
2(6):
750-757
DOI: 10.21873/cdp.10170
Profile and Potential Significance of Dendritic Cells in Head and Neck Squamous Cell Carcinoma
Cancer Diagnosis & Prognosis
Nov-Dec;
2(6):
758-763
DOI: 10.21873/cdp.10171
Case reports
Five-year Disease Control With Alectinib in a Patient With Metastatic ALK-rearranged Lung Adenocarcinoma
Cancer Diagnosis & Prognosis
Nov-Dec;
2(6):
707-710
DOI: 10.21873/cdp.10164
Octogenarians With Anaplastic Lymphoma Kinase-rearranged Non-small-cell Lung Cancer: A Case Series
Cancer Diagnosis & Prognosis
Nov-Dec;
2(6):
711-715
DOI: 10.21873/cdp.10165
A Malignant Tumor Developed Seven Years After Small Cell Lung Cancer Treated With Etoposide-containing Chemotherapy
Cancer Diagnosis & Prognosis
Nov-Dec;
2(6):
716-719
DOI: 10.21873/cdp.10166
Review articles
Adenoid Cystic Carcinoma (ACC) Infiltrating the Skull Base: A Systematic Review of Clinical Characteristics and Management Strategies
Cancer Diagnosis & Prognosis
Sep-Oct;
2(5):
503-511
DOI: 10.21873/cdp.10134
The Significance of Peritoneal Washing as a Prognostic Indicator for Ovarian Cancer Patients
Cancer Diagnosis & Prognosis
Sep-Oct;
2(5):
512-519
DOI: 10.21873/cdp.10135
Extent of Surgical Resection for Gastric Cancer: The Safety Distance Between the Tumor and the Proximal Resection Margin
Cancer Diagnosis & Prognosis
Sep-Oct;
2(5):
520-524
DOI: 10.21873/cdp.10136
Research articles
KIFC1: A Reliable Prognostic Biomarker in Rb-positive Triple-negative Breast Cancer Patients Treated With Doxorubicin in Combination With Abemaciclib
Cancer Diagnosis & Prognosis
Sep-Oct;
2(5):
525-532
DOI: 10.21873/cdp.10137
Effect of Bevacizumab on a Human Breast Cancer Model that Exhibited Palbociclib-resistance by RB Knockout
Cancer Diagnosis & Prognosis
Sep-Oct;
2(5):
533-541
DOI: 10.21873/cdp.10138
Variants in HOXB13, G132E and F127C, Are Associated With Prostate Cancer Risk in Japanese Men
Cancer Diagnosis & Prognosis
Sep-Oct;
2(5):
542-548
DOI: 10.21873/cdp.10139
The Effects of Vonoprazan Fumarate on the Tacrolimus Blood Concentration in Liver Transplant Recipients
Cancer Diagnosis & Prognosis
Sep-Oct;
2(5):
553-557
DOI: 10.21873/cdp.10141
Number of Examined Lymph Nodes as a Risk Factor for Recurrence in pT1N+ or pT2-3N0 Gastric Cancer
Cancer Diagnosis & Prognosis
Sep-Oct;
2(5):
558-563
DOI: 10.21873/cdp.10142
Endometrial Cancer Incidence in Patients With Atypical Endometrial Hyperplasia According to Mode of Management
Cancer Diagnosis & Prognosis
Sep-Oct;
2(5):
564-568
DOI: 10.21873/cdp.10143
Preoperative Alkaline Phosphatase-adjusted CA19-9 as a Superior Prognosticator for Extrahepatic Biliary Tract Cancer With Jaundice
Cancer Diagnosis & Prognosis
Sep-Oct;
2(5):
569-575
DOI: 10.21873/cdp.10144
KRAS Promoter Methylation Status and miR-18a-3p and miR-143 Expression in Patients With Wild-type KRAS Gene in Colorectal Cancer
Cancer Diagnosis & Prognosis
Sep-Oct;
2(5):
576-584
DOI: 10.21873/cdp.10145
Prognostic Significance of Low HER2 Expression in Patients With Metastatic Hormone Receptor-positive Breast Cancer Treated With First Line CDK4/6 Inhibitors: A Greek Multicenter Real-world Data Analysis
Cancer Diagnosis & Prognosis
Sep-Oct;
2(5):
585-591
DOI: 10.21873/cdp.10146
Case reports
Testicular Plasmacytoma Masking as Epididymo-orchitis in a Known Multiple Myeloma Patient
Cancer Diagnosis & Prognosis
Sep-Oct;
2(5):
549-552
DOI: 10.21873/cdp.10140
Arthroscopic Excision of Intra-articular AHRR-NCOA2– positive Angiofibroma of Soft Tissue of the Knee: A Case Report
Cancer Diagnosis & Prognosis
Sep-Oct;
2(5):
592-597
DOI: 10.21873/cdp.10147
Oligometastatic Lymph Node Recurrence Detected Using 18F-PSMA-1007 PET/CT in a Patient With Castration-resistant Prostate Cancer After Radiation Therapy
Cancer Diagnosis & Prognosis
Sep-Oct;
2(5):
598-602
DOI: 10.21873/cdp.10148
Review article
The Role of Decoy Receptor DcR3 in Gastrointestinal Malignancy
Cancer Diagnosis & Prognosis
Jul-Aug;
2(4):
411-421
DOI: 10.21873/cdp.10124
Research articles
An Analysis of the Impact of COVID-19 Pandemic-related Lockdown Measures on a Large Gastrointestinal Pathology Service in the United States
Cancer Diagnosis & Prognosis
Jul-Aug;
2(4):
422-428
DOI: 10.21873/cdp.10125
High SLC20A1 Expression Is Associated With Poor Prognosis for Radiotherapy of Estrogen Receptor-positive Breast Cancer
Cancer Diagnosis & Prognosis
Jul-Aug;
2(4):
429-442
DOI: 10.21873/cdp.10126
Validation of the Optimum Timing of Assessment of Tumor Infiltrating Lymphocytes During Preoperative Chemotherapy for Breast Cancer
Cancer Diagnosis & Prognosis
Jul-Aug;
2(4):
443-451
DOI: 10.21873/cdp.10127
Early Predictive Factors for Postoperative Pancreatic Fistula After Distal Pancreatectomy for Pancreatic Cancer
Cancer Diagnosis & Prognosis
Jul-Aug;
2(4):
452-461
DOI: 10.21873/cdp.10128
Appropriate Patient Status for Ra-223 Treatment in the Treatment Sequence for Castration-resistant Prostate Cancer
Cancer Diagnosis & Prognosis
Jul-Aug;
2(4):
462-470
DOI: 10.21873/cdp.10129
LI-RADS Classification and Outcomes of Hepatocellular Carcinoma Treated With Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation
Cancer Diagnosis & Prognosis
Jul-Aug;
2(4):
471-481
DOI: 10.21873/cdp.10130
Retrospective Analysis of Total Parietal Peritonectomy Without Systematic Lymphadenectomy for Advanced Epithelial Ovarian Cancer
Cancer Diagnosis & Prognosis
Jul-Aug;
2(4):
482-488
DOI: 10.21873/cdp.10131
Sodium Caseinate in Combination With Daunorubicin or Cytarabine Improves Survival of Mice With Long-established Leukemia
Cancer Diagnosis & Prognosis
Jul-Aug;
2(4):
496-502
DOI: 10.21873/cdp.10133
Case report
Fibulo-Scapho-Lunate Arthrodesis With Free Vascularized Fibular Graft for a Japanese Kyudo Archer With Osteosarcoma of the Left Distal Radius: A Case Report
Cancer Diagnosis & Prognosis
Jul-Aug;
2(4):
489-495
DOI: 10.21873/cdp.10132
Review article
Impact of Hippocampal Avoidance - Prophylactic Cranial Irradiation in Small Cell Lung Cancer Patients
Cancer Diagnosis & Prognosis
May-June;
2(3):
279-284
DOI: 10.21873/cdp.10105
Research articles
Circulating Cell-free DNA in Serum as a Marker for the Early Detection of Tumor Recurrence in Breast Cancer Patients
Cancer Diagnosis & Prognosis
May-June;
2(3):
285-292
DOI: 10.21873/cdp.10106
Intra-tumoral FGFR2 Expression Predicts Prognosis and Chemotherapy Response in Advanced HER2-positive Gastric Cancer Patients
Cancer Diagnosis & Prognosis
May-June;
2(3):
293-299
DOI: 10.21873/cdp.10107
Efficacy and Safety of mFOLFOX6 as Perioperative Chemotherapy for Resectable Liver Metastases from Colorectal Cancer: A Case–Control Study
Cancer Diagnosis & Prognosis
May-June;
2(3):
300-304
DOI: 10.21873/cdp.10108
Dysplastic Crypts in Asymmetric Branching in Ulcerative Colitis: A Preliminary Report
Cancer Diagnosis & Prognosis
May-June;
2(3):
305-307
DOI: 10.21873/cdp.10109
Gynecologic Oncology: Pelvic Exenteration for Advanced or Recurring Cervical Cancer – A Single Center Analysis
Cancer Diagnosis & Prognosis
May-June;
2(3):
308-315
DOI: 10.21873/cdp.10110
Prognostic Significance of Low HER2 Expression in Patients With Early Hormone Receptor Positive Breast Cancer
Cancer Diagnosis & Prognosis
May-June;
2(3):
316-323
DOI: 10.21873/cdp.10111
Association of Tumor PD-L1 Expression With Time on Treatment Using EGFR-TKIs in Patients With EGFR-Mutant Non-small Cell Lung Cancer
Cancer Diagnosis & Prognosis
May-June;
2(3):
324-329
DOI: 10.21873/cdp.10112
Direct Observation of Retinal Microvessels in Cancer Patients After Systemic Administration of Bevacizumab and Oxaliplatin
Cancer Diagnosis & Prognosis
May-June;
2(3):
330-335
DOI: 10.21873/cdp.10113
Associations Between Plasma Concentrations of Lenvatinib and Angiopoietin and Clinical Responses to Lenvatinib Therapy in Japanese Patients With Thyroid Cancer
Cancer Diagnosis & Prognosis
May-June;
2(3):
336-344
DOI: 10.21873/cdp.10114
Pre-operative Serum Albumin as a Potential Predictor of Benign Lesions in Renal Masses
Cancer Diagnosis & Prognosis
May-June;
2(3):
345-350
DOI: 10.21873/cdp.10115
Survival Outcomes of Patients With Primary Mediastinal Germ Cell Tumors: A Retrospective Single-institutional Experience
Cancer Diagnosis & Prognosis
May-June;
2(3):
352-359
DOI: 10.21873/cdp.10116
Total Risk Points Predict Short- and Long-term Outcomes Following Colorectal Cancer Resection in Older Patients
Cancer Diagnosis & Prognosis
May-June;
2(3):
360-368
DOI: 10.21873/cdp.10117
Cytogenetic Biomonitoring in Buccal Mucosa Cells from Seaport Dockers
Cancer Diagnosis & Prognosis
May-June;
2(3):
369-372
DOI: 10.21873/cdp.10118
Body Weight Change in Non-small Cell Lung Cancer Patients Treated With EGFR-TKI
Cancer Diagnosis & Prognosis
May-June;
2(3):
373-377
DOI: 10.21873/cdp.10119
Methylation of Tumor Suppressive miRNAs in Plasma from Patients With Pancreaticobiliary Diseases
Cancer Diagnosis & Prognosis
May-June;
2(3):
378-383
DOI: 10.21873/cdp.10120
CD103+ T Cells May Be a Useful Biomarker in Borrmann Type 4 Gastric Cancer
Cancer Diagnosis & Prognosis
May-June;
2(3):
384-390
DOI: 10.21873/cdp.10121
ZAP70 Activation Compensates for Loss of Class IA PI3K Isoforms Through Activation of the JAK–STAT3 Pathway
Cancer Diagnosis & Prognosis
May-June;
2(3):
391-404
DOI: 10.21873/cdp.10122
Identification of Germline Mutations in Genes Involved in Classic FAP in Patients from Northern Brazil
Cancer Diagnosis & Prognosis
May-June;
2(3):
405-410
DOI: 10.21873/cdp.10123
Review articles
Diagnosis and Surgical Treatment of Gastroenteropancreatic Neuroendocrine Neoplasms: A Literature Review
Cancer Diagnosis & Prognosis
Mar-Apr;
2(2):
115-125
DOI: 10.21873/cdp.10085
SIRT1 Expression Is a Promising Prognostic Biomarker in Esophageal Squamous Cell Carcinoma: A Systematic Review and Meta-analysis
Cancer Diagnosis & Prognosis
Mar-Apr;
2(2):
126-133
DOI: 10.21873/cdp.10086
A Brief Overview of Oncogenes and Signal Transduction Pathways in Gynecological Cancer
Cancer Diagnosis & Prognosis
Mar-Apr;
2(2):
134-143
DOI: 10.21873/cdp.10087
Role and Efficacy of Robotic-assisted Radical Antegrade Modular Pancreatosplenectomy (RAMPS) in Left-sided Pancreatic Cancer
Cancer Diagnosis & Prognosis
Mar-Apr;
2(2):
144-149
DOI: 10.21873/cdp.10088
Research articles
Evaluation of the Significance of Lymphatic, Microvascular and Perineural Invasion in Patients With Pancreatic Neuroendocrine Neoplasms
Cancer Diagnosis & Prognosis
Mar-Apr;
2(2):
150-159
DOI: 10.21873/cdp.10089
Intrahepatic Cholangiocarcinoma With Neither Intrahepatic Metastasis Nor Lymph Node Metastasis Is the Optimal Indication for Hepatectomy With Adjuvant Therapy
Cancer Diagnosis & Prognosis
Mar-Apr;
2(2):
160-166
DOI: 10.21873/cdp.10090
Worse Prognosis in the Symptomatic Patients With Lung Cancer – Czech Multicentric Study
Cancer Diagnosis & Prognosis
Mar-Apr;
2(2):
167-172
DOI: 10.21873/cdp.10091
Transabdominal Ultrasonography for Preoperative Diagnosis of Lymph Node Metastasis in Colon Cancer: A Retrospective Cohort Study
Cancer Diagnosis & Prognosis
Mar-Apr;
2(2):
173-183
DOI: 10.21873/cdp.10092
Clinical Significance of Serum Zinc Levels on the Development of Sarcopenia in Cirrhotic Patients
Cancer Diagnosis & Prognosis
Mar-Apr;
2(2):
184-193
DOI: 10.21873/cdp.10093
Outcomes of Sarcopenia Treatment for Malignant Bone and Soft Tissue Tumors in Elderly Patients
Cancer Diagnosis & Prognosis
Mar-Apr;
2(2):
194-200
DOI: 10.21873/cdp.10094
Short- and Long-term Outcome After Gastric Cancer Resection in Patients Aged 80 Years and Older
Cancer Diagnosis & Prognosis
Mar-Apr;
2(2):
201-209
DOI: 10.21873/cdp.10095
Perioperative Safety of Gastrectomy for Patients Receiving Antithrombotic Treatment
Cancer Diagnosis & Prognosis
Mar-Apr;
2(2):
210-215
DOI: 10.21873/cdp.10096
Efficacy of Pre-operative 18F-FDG PET/CT in Prognostic Prediction in Patients With Renal Cell Carcinoma
Cancer Diagnosis & Prognosis
Mar-Apr;
2(2):
216-222
DOI: 10.21873/cdp.10097
Impact of Regional Lymph Node Irradiation on Reducing Lymph Node Recurrence in Esophageal Cancer Patients
Cancer Diagnosis & Prognosis
Mar-Apr;
2(2):
223-231
DOI: 10.21873/cdp.10098
Distance of Peritoneum to Inferior Mesenteric Artery Predicts the Operation Time During Laparoscopic Colectomy for Sigmoid or Rectosigmoid Colon Cancer
Cancer Diagnosis & Prognosis
Mar-Apr;
2(2):
240-246
DOI: 10.21873/cdp.10100
Favorable Impact on Postoperative Abdominal Symptoms in Robot-assisted Radical Prostatectomy Using Enhanced Recovery After Surgery Protocol
Cancer Diagnosis & Prognosis
Mar-Apr;
2(2):
247-252
DOI: 10.21873/cdp.10101
Pan-cancer Bioinformatics Analysis of the Double-edged Role of Hypoxia-inducible Factor 1α (HIF-1α) in Human Cancer
Cancer Diagnosis & Prognosis
Mar-Apr;
2(2):
263-278
DOI: 10.21873/cdp.10104
Case reports
Undifferentiated Pleomorphic Sarcoma of the Conjunctiva: A Case Report and Review of the Literature
Cancer Diagnosis & Prognosis
Mar-Apr;
2(2):
232-239
DOI: 10.21873/cdp.10099
Combination of Pembrolizumab With Platinum-containing Chemotherapy for Pulmonary Enteric Adenocarcinoma
Cancer Diagnosis & Prognosis
Mar-Apr;
2(2):
253-257
DOI: 10.21873/cdp.10102
A Case Report of Radiotherapy for Skull Lesions of Langerhans Cell Histiocytosis With Dural Invasion
Cancer Diagnosis & Prognosis
Mar-Apr;
2(2):
258-262
DOI: 10.21873/cdp.10103
Review article
Impact of Ubiquitination Signaling Pathway Modifications on Oral Carcinoma
Cancer Diagnosis & Prognosis
Jan-Feb;
2(1):
1-6
DOI: 10.21873/cdp.10069
Research articles
Visual Counting and Automated Image-analytic Assessment of Ki-67 and their Prognostic Value in Synovial Sarcoma
Cancer Diagnosis & Prognosis
Jan-Feb;
2(1):
7-14
DOI: 10.21873/cdp.10070
Hyaluronic Acid May Be a Predictive Biomarker for Thrombocytopenia and Liver Dysfunction After Oxaliplatin-based Chemotherapy
Cancer Diagnosis & Prognosis
Jan-Feb;
2(1):
15-24
DOI: 10.21873/cdp.10071
Improvement of Medical Treatment in Japanese Patients With Metastatic Renal Cell Carcinoma
Cancer Diagnosis & Prognosis
Jan-Feb;
2(1):
25-30
DOI: 10.21873/cdp.10072
The Impact of Metastatic Lymph Node Size on Long-term Outcomes for pStage III Colon Cancer
Cancer Diagnosis & Prognosis
Jan-Feb;
2(1):
31-37
DOI: 10.21873/cdp.10073
Predictive Value of the Prognostic Nutritional Index in Neoadjuvant Chemoradiotherapy for Rectal Cancer
Cancer Diagnosis & Prognosis
Jan-Feb;
2(1):
38-48
DOI: 10.21873/cdp.10074
Preoperative Predictors of Lymph Node Invasion and Biochemical Recurrence in High-risk Prostate Cancer
Cancer Diagnosis & Prognosis
Jan-Feb;
2(1):
49-54
DOI: 10.21873/cdp.10075
Immune-related Thyroid Dysfunction (irTD) in Non-small Cell Lung Cancer (NSCLC) Correlates With Response and Survival
Cancer Diagnosis & Prognosis
Jan-Feb;
2(1):
55-63
DOI: 10.21873/cdp.10076
Inflammation-based Indexes Upon Adjuvant Chemotherapy Initiation as a Predictor of Relapse After Curative Resection of Colorectal Cancer With an Oxaliplatin-based Regimen
Cancer Diagnosis & Prognosis
Jan-Feb;
2(1):
64-70
DOI: 10.21873/cdp.10077
Age-related Survival Outcomes for Pancreatic Cancer by Age
Cancer Diagnosis & Prognosis
Jan-Feb;
2(1):
71-77
DOI: 10.21873/cdp.10078
Clinical Implication of KRAS Mutation Variants in Patients With Resected Colon Cancer
Cancer Diagnosis & Prognosis
Jan-Feb;
2(1):
78-83
DOI: 10.21873/cdp.10079
FOLFIRINOX as First-line Chemotherapy in Japanese Patients Suffering from Metastatic Pancreatic Cancer (KOBE FOLFIRINOX Study)
Cancer Diagnosis & Prognosis
Jan-Feb;
2(1):
101-106
DOI: 10.21873/cdp.10083
Somatic Mutations in TP53 Gene in Colombian Patients With Non-melanoma Skin Cancer
Cancer Diagnosis & Prognosis
Jan-Feb;
2(1):
107-114
DOI: 10.21873/cdp.10084
Case reports
Complete Response of a Mutated BRCA2 Metastatic Clear Cell Endometrial Adenocarcinoma to the Poly (ADP ribose) Polymerase (PARP) Inhibitor Olaparib
Cancer Diagnosis & Prognosis
Jan-Feb;
2(1):
84-86
DOI: 10.21873/cdp.10080
A Case of Secretory Carcinoma in a Patient With a History of Contralateral Medullary Carcinoma
Cancer Diagnosis & Prognosis
Jan-Feb;
2(1):
87-92
DOI: 10.21873/cdp.10081
Monostotic Fibrous Dysplasia in the Femur Strongly Expressing RANKL With Concomitant Osteoporotic Vertebral Compression Fracture: A Case Report
Cancer Diagnosis & Prognosis
Jan-Feb;
2(1):
93-100
DOI: 10.21873/cdp.10082
Review article
Diarrhea in Placebo Arms of Cancer Studies
Cancer Diagnosis & Prognosis
Nov-Dec;
1(5):
379-385
DOI: 10.21873/cdp.10050
Research articles
Rectal Phenotype of Perianal Paget Disease: Rare Concomitant Phenomena
Cancer Diagnosis & Prognosis
Nov-Dec;
1(5):
387-392
DOI: 10.21873/cdp.10051
Occurrence of Second Primary Malignancies in Patients With Primary Optic Nerve Gliomas: A Surveillance, Epidemiology, and End Results Analysis
Cancer Diagnosis & Prognosis
Nov-Dec;
1(5):
393-398
DOI: 10.21873/cdp.10052
Evaluation of Early Prognostic Factors in Patients With Pancreatic Ductal Adenocarcinoma Receiving Gemcitabine Together With Nab-paclitaxel
Cancer Diagnosis & Prognosis
Nov-Dec;
1(5):
399-409
DOI: 10.21873/cdp.10053
Clinical Efficacy of Liver Tumor Biopsy With Radiofrequency Ablation of the Puncture Route Using a Co-access Needle
Cancer Diagnosis & Prognosis
Nov-Dec;
1(5):
411-416
DOI: 10.21873/cdp.10054
Treatment Strategy for Cancer-associated Venous Thromboembolism During Chemotherapy: The Keep ACT2 Concept
Cancer Diagnosis & Prognosis
Nov-Dec;
1(5):
417-422
DOI: 10.21873/cdp.10055
COVID-19 Screening of Breast Cancer Patients During Treatment: A Single Center Experience in Japan
Cancer Diagnosis & Prognosis
Nov-Dec;
1(5):
423-425
DOI: 10.21873/cdp.10056
Transoral Endoscopic Examination of the Oropharynx With Tongue Protrusion, Phonation, and Open Mouth
Cancer Diagnosis & Prognosis
Nov-Dec;
1(5):
427-434
DOI: 10.21873/cdp.10057
Absolute Lymphocyte Count, Platelet-to-Lymphocyte Ratio, and Overall Survival in Eribulin-treated HER2-negative Metastatic Breast Cancer Patients
Cancer Diagnosis & Prognosis
Nov-Dec;
1(5):
435-441
DOI: 10.21873/cdp.10058
Vein-first Lobectomy for Lung Cancer Assessed According to the Status of Clustered Circulating Tumour Cells
Cancer Diagnosis & Prognosis
Nov-Dec;
1(5):
443-450
DOI: 10.21873/cdp.10059
Efficacy of Combination Chemotherapy With Docetaxel, Estramustine and Carboplatin in Men With Castration-resistant Prostate Cancer
Cancer Diagnosis & Prognosis
Nov-Dec;
1(5):
451-457
DOI: 10.21873/cdp.10060
Clinical Outcomes of Three or More Courses of First-line Chemotherapy for Metastatic Urothelial Carcinoma
Cancer Diagnosis & Prognosis
Nov-Dec;
1(5):
459-464
DOI: 10.21873/cdp.10061
Risk of Outlet Obstruction Associated With Defunctioning Loop Ileostomy in Rectal Cancer Surgery
Cancer Diagnosis & Prognosis
Nov-Dec;
1(5):
465-470
DOI: 10.21873/cdp.10062
The Systemic Immune Markers at Diagnosis Can Predict the Survival Benefit in Advanced Breast Cancer
Cancer Diagnosis & Prognosis
Nov-Dec;
1(5):
471-478
DOI: 10.21873/cdp.10063
Prognostic Utility of Geriatric Nutritional Risk Index After Curative Resection of Colorectal Cancer: A Propensity Score-matched Study
Cancer Diagnosis & Prognosis
Nov-Dec;
1(5):
479-484
DOI: 10.21873/cdp.10064
Absolute Increase in the Number and Proportion of Peripheral Eosinophils Associated With Immune Checkpoint Inhibitor Treatment in Non-small Cell Lung Cancer Patients
Cancer Diagnosis & Prognosis
Nov-Dec;
1(5):
485-490
DOI: 10.21873/cdp.10065
Prognostic Value of Lymphocyte-to-Monocyte Ratio for Japanese Patients With Differentiated Thyroid Cancer Treated With Sorafenib Therapy
Cancer Diagnosis & Prognosis
Nov-Dec;
1(5):
491-498
DOI: 10.21873/cdp.10066
Case reports
Undifferentiated Carcinoma After Laparoscopic Surgery for a Cystic Ovarian Tumour: A Case Study
Cancer Diagnosis & Prognosis
Nov-Dec;
1(5):
499-505
DOI: 10.21873/cdp.10067
Gastric Eosinophilic Granuloma Related to Anisakiasis Resected by Laparoscopic and Endoscopic Cooperative Surgery
Cancer Diagnosis & Prognosis
Nov-Dec;
1(5):
507-512
DOI: 10.21873/cdp.10068
Review article
Bladder Cancer-related microRNAs With In Vivo Efficacy in Preclinical Models
Cancer Diagnosis & Prognosis
Sep-Oct;
1(4):
245-263
DOI: 10.21873/cdp.10033
Research articles
History-taking, Clinical Signs, Tests and Scores for Detection of Non-organic Dyspepsia (NOD) Among Patients With Acute Abdominal Pain (AAP)
Cancer Diagnosis & Prognosis
Sep-Oct;
1(4):
265-274
DOI: 10.21873/cdp.10034
PTPN14 Mutations and Cervical Cancer
Cancer Diagnosis & Prognosis
Sep-Oct;
1(4):
275-277
DOI: 10.21873/cdp.10035
Laparoscopic Surgery Reduces Risk of Postoperative Complications and Non Cancer-related Survival in Patients Over 80 Years Old With Colorectal Cancer
Cancer Diagnosis & Prognosis
Sep-Oct;
1(4):
297-301
DOI: 10.21873/cdp.10039
Changes in Neutrophil-to-lymphocyte Ratio Predict Efficacy of Trabectedin for Soft-tissue Sarcoma
Cancer Diagnosis & Prognosis
Sep-Oct;
1(4):
303-308
DOI: 10.21873/cdp.10040
Ultrasonography Combined With Contrast-enhanced Ultrasonography Can Predict Lymphocyte-predominant Breast Cancer
Cancer Diagnosis & Prognosis
Sep-Oct;
1(4):
309-316
DOI: 10.21873/cdp.10041
New Technique of Laparoscopic Paraaortic Lymph Node Dissection for Colorectal Cancer Using Fluorescence Navigation
Cancer Diagnosis & Prognosis
Sep-Oct;
1(4):
317-322
DOI: 10.21873/cdp.10042
Risk Scoring System for Ra-223 Discontinuation and Its Effect on Prognosis: A Retrospective Study
Cancer Diagnosis & Prognosis
Sep-Oct;
1(4):
323-330
DOI: 10.21873/cdp.10043
Correlation Between the Transient Elevation of Peripheral Eosinophil Count During Radiotherapy and Acute Diarrhea
Cancer Diagnosis & Prognosis
Sep-Oct;
1(4):
331-337
DOI: 10.21873/cdp.10044
The Clinical Features of Multicentric Extra-abdominal Desmoid Tumors
Cancer Diagnosis & Prognosis
Sep-Oct;
1(4):
339-343
DOI: 10.21873/cdp.10045
Evaluation of the Extent of Variant Histology in Urothelial Carcinoma as a Predictive Marker of Clinical Outcomes After Radical Cystectomy
Cancer Diagnosis & Prognosis
Sep-Oct;
1(4):
345-351
DOI: 10.21873/cdp.10046
Combination of Performance Status and Lymphocyte-monocyte Ratio as a Novel Prognostic Marker for Patients With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
Cancer Diagnosis & Prognosis
Sep-Oct;
1(4):
353-361
DOI: 10.21873/cdp.10047
High Expression of PEA15 Is Associated With Patient Survival in Malignant Pleural Mesothelioma
Cancer Diagnosis & Prognosis
Sep-Oct;
1(4):
371-377
DOI: 10.21873/cdp.10049
Case reports
Squamous Cell Carcinoma Ex Pleomorphic Adenoma of the Parotid Gland: Unusual Entity and Diagnostic Pitfalls
Cancer Diagnosis & Prognosis
Sep-Oct;
1(4):
279-283
DOI: 10.21873/cdp.10036
Pancreatic-type Mixed Acinar-neuroendocrine Carcinoma of the Stomach: A Case Report and Literature Review
Cancer Diagnosis & Prognosis
Sep-Oct;
1(4):
285-288
DOI: 10.21873/cdp.10037
Exfoliative Dermatitis as a Para-neoplastic Syndrome of Prostate Adenocarcinoma: A Rare Case Report With Literature Review
Cancer Diagnosis & Prognosis
Sep-Oct;
1(4):
289-295
DOI: 10.21873/cdp.10038
A Large Thymoma Resected via Left Antero-lateral Thoracotomy
Cancer Diagnosis & Prognosis
Sep-Oct;
1(4):
363-370
DOI: 10.21873/cdp.10048
Review articles
Common Malignancies During Pregnancy: A Comprehensive Review
Cancer Diagnosis & Prognosis
Jul-Aug;
1(3):
103-109
DOI: 10.21873/cdp.10015
The Relevance of Aurora Kinase Inhibition in Hematological Malignancies
Cancer Diagnosis & Prognosis
Jul-Aug;
1(3):
111-126
DOI: 10.21873/cdp.10016
Research articles
Discordant PET Findings and a High Relapse Rate Characterize Hispanics With Hodgkin’s Lymphoma Treated With ABVD
Cancer Diagnosis & Prognosis
Jul-Aug;
1(3):
127-133
DOI: 10.21873/cdp.10017
Influence of Concomitant Polypharmacy on Docetaxel-induced Febrile Neutropenia
Cancer Diagnosis & Prognosis
Jul-Aug;
1(3):
135-141
DOI: 10.21873/cdp.10018
Multimodal Evaluation of Voice Outcome in Early Glottic Cancers Treated With Definitive Radiotherapy
Cancer Diagnosis & Prognosis
Jul-Aug;
1(3):
143-149
DOI: 10.21873/cdp.10019
Clinical Impact of Operative Order in Laparoscopic Simultaneous Resection for Synchronous Colorectal Liver Metastases
Cancer Diagnosis & Prognosis
Jul-Aug;
1(3):
151-156
DOI: 10.21873/cdp.10020
Improved Chemotherapy Outcomes of Patients With Small-cell Lung Cancer Treated With Combined Alkalization Therapy and Intravenous Vitamin C
Cancer Diagnosis & Prognosis
Jul-Aug;
1(3):
157-163
DOI: 10.21873/cdp.10021
Recurrence of Lymph Node Micrometastases After Radiotherapy for Head and Neck Carcinoma: A Propensity Score-matched Study
Cancer Diagnosis & Prognosis
Jul-Aug;
1(3):
165-172
DOI: 10.21873/cdp.10022
Immune Checkpoint Inhibitor for Non-small Cell Lung Cancer With Negative or Low Tumor PD-L1 Expression
Cancer Diagnosis & Prognosis
Jul-Aug;
1(3):
173-177
DOI: 10.21873/cdp.10023
Impact of Hypertension on Early Renal Dysfunction in Japanese Prostate Cancer Patients Treated With Androgen Deprivation Therapy
Cancer Diagnosis & Prognosis
Jul-Aug;
1(3):
179-183
DOI: 10.21873/cdp.10024
Survival Benefit of Neoadjuvant Chemotherapy for Locally Advanced Adenocarcinoma of Esophagogastric Junction
Cancer Diagnosis & Prognosis
Jul-Aug;
1(3):
185-191
DOI: 10.21873/cdp.10025
VMAT Planning With Xe-CT Functional Images Enables Radiotherapy Planning With Consideration of Lung Function
Cancer Diagnosis & Prognosis
Jul-Aug;
1(3):
193-200
DOI: 10.21873/cdp.10026
Significance of 5-Aminolevulinic Acid-mediated Photodynamic Diagnosis Following Standard Transurethral Resection in Non-muscle Invasive Bladder Cancer
Cancer Diagnosis & Prognosis
Jul-Aug;
1(3):
201-205
DOI: 10.21873/cdp.10027
Absolute Lymphocyte Counts After Lenalidomide Initiation may Predict the Prognosis of Patients With Relapsed or Refractory Multiple Myeloma
Cancer Diagnosis & Prognosis
Jul-Aug;
1(3):
221-229
DOI: 10.21873/cdp.10030
Tumour-associated Angiogenesis and Intermediate Blood Vessels in Renal Cell Carcinoma
Cancer Diagnosis & Prognosis
Jul-Aug;
1(3):
231-234
DOI: 10.21873/cdp.10031
Proteomic Analysis of the Non-genetic Response to Cisplatin in Lung Cancer Cells
Cancer Diagnosis & Prognosis
Jul-Aug;
1(3):
235-243
DOI: 10.21873/cdp.10032
Case reports
Successful Response to Nivolumab Plus Ipilimumab Therapy in a Hemodialysis Patient With Metastatic Renal Cell Carcinoma
Cancer Diagnosis & Prognosis
Jul-Aug;
1(3):
207-211
DOI: 10.21873/cdp.10028
Identification of a New Variant of PUF60 Gene: Case Presentation and Literature Review
Cancer Diagnosis & Prognosis
Jul-Aug;
1(3):
213-219
DOI: 10.21873/cdp.10029
Research articles
Real-time IR700 Fluorescence Imaging During Near-infrared Photoimmunotherapy Using a Clinically-approved Camera for Indocyanine Green
Cancer Diagnosis & Prognosis
May-June;
1(2):
29-34
DOI: 10.21873/cdp.10005
Maintenance Therapy With Bortezomib and Dexamethasone for Transplant-ineligible Patients With Multiple Myeloma
Cancer Diagnosis & Prognosis
May-June;
1(2):
35-42
DOI: 10.21873/cdp.10006
Geriatric Nutritional Risk Index Predicts Poor Prognosis of Patients After Curative Surgery for Gastric Cancer
Cancer Diagnosis & Prognosis
May-June;
1(2):
43-52
DOI: 10.21873/cdp.10007
Stereotactic Body Radiation Therapy Boost in Patients With Cervical Cancer Ineligible for Brachytherapy
Cancer Diagnosis & Prognosis
May-June;
1(2):
53-60
DOI: 10.21873/cdp.10008
Visceral Adipose Mass and Radiation Pneumonitis After Concurrent Chemoradiotherapy in Patients With Non-small-cell Lung Cancer
Cancer Diagnosis & Prognosis
May-June;
1(2):
61-67
DOI: 10.21873/cdp.10009
Clinical Features of Primary Vitreoretinal Lymphoma: A Single-center Study
Cancer Diagnosis & Prognosis
May-June;
1(2):
69-75
DOI: 10.21873/cdp.10010
Cannabidiol Μay Prolong Survival in Patients With Glioblastoma Multiforme
Cancer Diagnosis & Prognosis
May-June;
1(2):
77-82
DOI: 10.21873/cdp.10011
Initial Experience of Atezolizumab Plus Bevacizumab for Advanced Hepatocellular Carcinoma in Clinical Practice
Cancer Diagnosis & Prognosis
May-June;
1(2):
83-88
DOI: 10.21873/cdp.10012
Impact of Smoking History on Pulmonary Metastasis-free Survival in Patients With Soft-tissue Sarcoma
Cancer Diagnosis & Prognosis
May-June;
1(2):
89-94
DOI: 10.21873/cdp.10013
Effect of Sucrose on Cisplatin-induced Fatigue-like Behavior in Mice: Comparison With Fructose and Glucose
Cancer Diagnosis & Prognosis
May-June;
1(2):
95-102
DOI: 10.21873/cdp.10014
Research articles
Switching Patients With Prostate Cancer from GnRH Antagonist to Long-acting LHRH Agonist for Androgen Deprivation: Reducing Hospital Visits During the Coronavirus Pandemic
Cancer Diagnosis & Prognosis
Mar-Apr;
1(1):
1-5
DOI: 10.21873/cdp.10000
Treatment at an Inexperienced Center Suggests Worse Prognosis of Metastatic Germ Cell Tumors
Cancer Diagnosis & Prognosis
Mar-Apr;
1(1):
13-17
DOI: 10.21873/cdp.10002
Case reports
An Autopsy Case of Metastatic Melanoma Originating from the Nasal Cavity That Was Treated With Nivolumab and Ipilimumab
Cancer Diagnosis & Prognosis
Mar-Apr;
1(1):
7-12
DOI: 10.21873/cdp.10001
A Treatment-free Interval Allowed by Ponatinib as Fourth-line Therapy
Cancer Diagnosis & Prognosis
Mar-Apr;
1(1):
19-22
DOI: 10.21873/cdp.10003
Management of Diagnosis and Treatment in a Case of Fibrolamellar Carcinoma
Cancer Diagnosis & Prognosis
Mar-Apr;
1(1):
23-28
DOI: 10.21873/cdp.10004
